false--12-31 Q2 2019 0000928054 FLOTEK INDUSTRIES INC/CN 0.001 0.001 0.001 0.95 0.95 0.95 1190000 1676000 900000 700000 0.0001 0.0001 80000000 80000000 57342279 57688578 P2Y 0 0 2400000 18400000 0.0001 0.0001 100000 100000 0 0 0 0 3770224 3947982 0 0 0 0000928054 2019-01-01 2019-06-30 0000928054 2019-07-31 0000928054 2018-12-31 0000928054 2019-06-30 0000928054 2018-04-01 2018-06-30 0000928054 2019-04-01 2019-06-30 0000928054 2018-01-01 2018-06-30 0000928054 2017-12-31 0000928054 2018-06-30 0000928054 us-gaap:RetainedEarningsMember 2019-06-30 0000928054 us-gaap:AdditionalPaidInCapitalMember 2019-04-01 2019-06-30 0000928054 us-gaap:TreasuryStockMember 2019-03-31 0000928054 2019-03-31 0000928054 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-03-31 0000928054 us-gaap:CommonStockMember 2019-06-30 0000928054 us-gaap:RetainedEarningsMember 2019-03-31 0000928054 us-gaap:TreasuryStockMember 2019-06-30 0000928054 us-gaap:TreasuryStockMember 2019-04-01 2019-06-30 0000928054 us-gaap:CommonStockMember 2019-04-01 2019-06-30 0000928054 us-gaap:RetainedEarningsMember 2019-04-01 2019-06-30 0000928054 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-04-01 2019-06-30 0000928054 us-gaap:AdditionalPaidInCapitalMember 2019-03-31 0000928054 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-06-30 0000928054 us-gaap:CommonStockMember 2019-03-31 0000928054 us-gaap:NoncontrollingInterestMember 2019-03-31 0000928054 us-gaap:AdditionalPaidInCapitalMember 2019-06-30 0000928054 us-gaap:NoncontrollingInterestMember 2019-06-30 0000928054 us-gaap:AdditionalPaidInCapitalMember 2019-01-01 2019-06-30 0000928054 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2019-01-01 2019-06-30 0000928054 us-gaap:CommonStockMember 2018-12-31 0000928054 us-gaap:AdditionalPaidInCapitalMember 2018-12-31 0000928054 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-12-31 0000928054 us-gaap:TreasuryStockMember 2019-01-01 2019-06-30 0000928054 us-gaap:CommonStockMember 2019-01-01 2019-06-30 0000928054 us-gaap:NoncontrollingInterestMember 2018-12-31 0000928054 us-gaap:TreasuryStockMember 2018-12-31 0000928054 us-gaap:RetainedEarningsMember 2019-01-01 2019-06-30 0000928054 us-gaap:RetainedEarningsMember 2018-12-31 0000928054 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-04-01 2018-06-30 0000928054 us-gaap:NoncontrollingInterestMember 2018-04-01 2018-06-30 0000928054 us-gaap:TreasuryStockMember 2018-06-30 0000928054 us-gaap:AdditionalPaidInCapitalMember 2018-04-01 2018-06-30 0000928054 us-gaap:RetainedEarningsMember 2018-03-31 0000928054 us-gaap:CommonStockMember 2018-06-30 0000928054 us-gaap:TreasuryStockMember 2018-04-01 2018-06-30 0000928054 us-gaap:TreasuryStockMember 2018-03-31 0000928054 us-gaap:CommonStockMember 2018-03-31 0000928054 us-gaap:RetainedEarningsMember 2018-06-30 0000928054 2018-03-31 0000928054 us-gaap:CommonStockMember 2018-04-01 2018-06-30 0000928054 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-03-31 0000928054 us-gaap:NoncontrollingInterestMember 2018-03-31 0000928054 us-gaap:AdditionalPaidInCapitalMember 2018-03-31 0000928054 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-06-30 0000928054 us-gaap:NoncontrollingInterestMember 2018-06-30 0000928054 us-gaap:AdditionalPaidInCapitalMember 2018-06-30 0000928054 us-gaap:RetainedEarningsMember 2018-04-01 2018-06-30 0000928054 us-gaap:TreasuryStockMember 2017-12-31 0000928054 us-gaap:AdditionalPaidInCapitalMember 2017-12-31 0000928054 us-gaap:AdditionalPaidInCapitalMember 2018-01-01 2018-06-30 0000928054 us-gaap:TreasuryStockMember 2018-01-01 2018-06-30 0000928054 us-gaap:CommonStockMember 2018-01-01 2018-06-30 0000928054 us-gaap:CommonStockMember 2017-12-31 0000928054 us-gaap:RetainedEarningsMember 2018-01-01 2018-06-30 0000928054 us-gaap:RetainedEarningsMember 2017-12-31 0000928054 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2018-01-01 2018-06-30 0000928054 us-gaap:NoncontrollingInterestMember 2017-12-31 0000928054 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2017-12-31 0000928054 us-gaap:NoncontrollingInterestMember 2018-01-01 2018-06-30 0000928054 us-gaap:AccountingStandardsUpdate201602Member 2019-01-01 0000928054 us-gaap:DiscontinuedOperationsHeldforsaleMember ftk:ConsumerandIndustrialChemicalTechnologiesMember 2018-12-31 0000928054 us-gaap:DiscontinuedOperationsHeldforsaleMember ftk:ConsumerandIndustrialChemicalTechnologiesMember 2019-06-30 0000928054 ftk:WorkingAdjustmentPeriod1Member us-gaap:DiscontinuedOperationsDisposedOfBySaleMember ftk:ConsumerandIndustrialChemicalTechnologiesMember 2019-02-28 2019-02-28 0000928054 ftk:WorkingAdjustmentPeriod1Member us-gaap:DiscontinuedOperationsDisposedOfBySaleMember ftk:ConsumerandIndustrialChemicalTechnologiesMember 2019-02-28 0000928054 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember ftk:ConsumerandIndustrialChemicalTechnologiesMember 2019-02-28 0000928054 ftk:WorkingAdjustmentPeriod3Member us-gaap:DiscontinuedOperationsDisposedOfBySaleMember ftk:ConsumerandIndustrialChemicalTechnologiesMember 2019-02-28 2019-02-28 0000928054 ftk:WorkingAdjustmentPeriod2Member us-gaap:DiscontinuedOperationsDisposedOfBySaleMember ftk:ConsumerandIndustrialChemicalTechnologiesMember 2019-02-28 2019-02-28 0000928054 ftk:WorkingAdjustmentPeriod4Member us-gaap:DiscontinuedOperationsDisposedOfBySaleMember ftk:ConsumerandIndustrialChemicalTechnologiesMember 2019-02-28 2019-02-28 0000928054 ftk:WorkingAdjustmentPeriod24Member us-gaap:DiscontinuedOperationsDisposedOfBySaleMember ftk:ConsumerandIndustrialChemicalTechnologiesMember 2019-02-28 0000928054 us-gaap:DiscontinuedOperationsDisposedOfBySaleMember ftk:ConsumerandIndustrialChemicalTechnologiesMember 2019-01-01 2019-06-30 0000928054 us-gaap:DiscontinuedOperationsHeldforsaleMember ftk:ConsumerandIndustrialChemicalTechnologiesMember 2019-04-01 2019-06-30 0000928054 us-gaap:DiscontinuedOperationsHeldforsaleMember ftk:ConsumerandIndustrialChemicalTechnologiesMember 2018-04-01 2018-06-30 0000928054 us-gaap:DiscontinuedOperationsHeldforsaleMember ftk:ConsumerandIndustrialChemicalTechnologiesMember 2018-01-01 2018-06-30 0000928054 us-gaap:DiscontinuedOperationsHeldforsaleMember ftk:ConsumerandIndustrialChemicalTechnologiesMember 2019-01-01 2019-06-30 0000928054 srt:MaximumMember 2019-01-01 2019-06-30 0000928054 srt:MinimumMember 2019-01-01 2019-06-30 0000928054 us-gaap:ServiceMember 2019-01-01 2019-06-30 0000928054 us-gaap:ProductMember 2018-01-01 2018-06-30 0000928054 us-gaap:ProductMember 2019-04-01 2019-06-30 0000928054 us-gaap:ServiceMember 2018-01-01 2018-06-30 0000928054 us-gaap:ServiceMember 2019-04-01 2019-06-30 0000928054 us-gaap:ServiceMember 2018-04-01 2018-06-30 0000928054 us-gaap:ProductMember 2019-01-01 2019-06-30 0000928054 us-gaap:ProductMember 2018-04-01 2018-06-30 0000928054 us-gaap:TransportationEquipmentMember 2019-06-30 0000928054 us-gaap:AssetUnderConstructionMember 2018-12-31 0000928054 us-gaap:LandMember 2018-12-31 0000928054 us-gaap:FurnitureAndFixturesMember 2018-12-31 0000928054 ftk:ComputerEquipmentandSoftwareMember 2018-12-31 0000928054 us-gaap:LandMember 2019-06-30 0000928054 us-gaap:FurnitureAndFixturesMember 2019-06-30 0000928054 us-gaap:BuildingAndBuildingImprovementsMember 2019-06-30 0000928054 us-gaap:MachineryAndEquipmentMember 2019-06-30 0000928054 us-gaap:AssetUnderConstructionMember 2019-06-30 0000928054 ftk:ComputerEquipmentandSoftwareMember 2019-06-30 0000928054 us-gaap:BuildingAndBuildingImprovementsMember 2018-12-31 0000928054 us-gaap:TransportationEquipmentMember 2018-12-31 0000928054 us-gaap:MachineryAndEquipmentMember 2018-12-31 0000928054 ftk:EnergyChemistryTechnologiesMember 2018-04-01 2018-06-30 0000928054 ftk:AcquiredIntangibleAssetsMember 2018-12-31 0000928054 us-gaap:CustomerListsMember 2019-06-30 0000928054 us-gaap:CustomerListsMember 2018-12-31 0000928054 us-gaap:PatentedTechnologyMember 2019-06-30 0000928054 ftk:DeferredFinancingCostsMember 2018-12-31 0000928054 us-gaap:TradeNamesMember 2019-06-30 0000928054 ftk:AcquiredIntangibleAssetsMember 2019-06-30 0000928054 us-gaap:PatentedTechnologyMember 2018-12-31 0000928054 us-gaap:TradeNamesMember 2019-06-30 0000928054 us-gaap:TradeNamesMember 2018-12-31 0000928054 us-gaap:TradeNamesMember 2018-12-31 0000928054 ftk:DeferredFinancingCostsMember 2019-06-30 0000928054 us-gaap:RevolvingCreditFacilityMember ftk:RestatedRevolvingCreditTermLoanandSecurityAgreementMember us-gaap:LetterOfCreditMember 2013-05-10 0000928054 ftk:RestatedRevolvingCreditTermLoanandSecurityAgreementMember us-gaap:LineOfCreditMember 2013-05-10 0000928054 us-gaap:RevolvingCreditFacilityMember 2018-12-31 0000928054 us-gaap:RevolvingCreditFacilityMember 2019-06-30 0000928054 us-gaap:RestrictedStockUnitsRSUMember 2019-04-01 2019-06-30 0000928054 us-gaap:RestrictedStockUnitsRSUMember 2018-04-01 2018-06-30 0000928054 us-gaap:RestrictedStockUnitsRSUMember 2018-01-01 2018-06-30 0000928054 us-gaap:RestrictedStockUnitsRSUMember 2019-01-01 2019-06-30 0000928054 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2018-12-31 0000928054 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2018-12-31 0000928054 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2019-06-30 0000928054 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2019-06-30 0000928054 2018-07-01 2018-12-31 0000928054 2009-11-09 2009-11-09 0000928054 ftk:ShareRepurchaseProgramJune2015Member 2015-06-30 0000928054 2009-11-09 0000928054 ftk:ShareRepurchaseProgramJune2015Member 2015-06-01 2017-12-31 0000928054 ftk:ShareRepurchaseProgramJune2015Member 2019-04-01 2019-06-30 0000928054 ftk:ShareRepurchaseProgramJune2015Member 2019-01-01 2019-06-30 0000928054 ftk:ShareRepurchaseProgramJune2015Member 2018-04-01 2018-06-30 0000928054 ftk:ShareRepurchaseProgramJune2015Member 2018-01-01 2018-06-30 0000928054 us-gaap:SegmentContinuingOperationsMember 2018-12-31 0000928054 us-gaap:OperatingSegmentsMember ftk:EnergyChemistryTechnologiesMember 2018-12-31 0000928054 us-gaap:OperatingSegmentsMember ftk:EnergyChemistryTechnologiesMember 2019-06-30 0000928054 us-gaap:CorporateNonSegmentMember 2019-06-30 0000928054 us-gaap:SegmentDiscontinuedOperationsMember 2018-12-31 0000928054 us-gaap:SegmentContinuingOperationsMember 2019-06-30 0000928054 us-gaap:CorporateNonSegmentMember 2018-12-31 0000928054 us-gaap:SegmentDiscontinuedOperationsMember 2019-06-30 0000928054 us-gaap:OperatingSegmentsMember ftk:EnergyChemistryTechnologiesMember 2019-04-01 2019-06-30 0000928054 us-gaap:CorporateNonSegmentMember 2019-04-01 2019-06-30 0000928054 us-gaap:CorporateNonSegmentMember 2018-04-01 2018-06-30 0000928054 us-gaap:OperatingSegmentsMember ftk:EnergyChemistryTechnologiesMember 2018-04-01 2018-06-30 0000928054 us-gaap:OperatingSegmentsMember ftk:EnergyChemistryTechnologiesMember 2019-01-01 2019-06-30 0000928054 us-gaap:OperatingSegmentsMember ftk:EnergyChemistryTechnologiesMember 2018-01-01 2018-06-30 0000928054 us-gaap:CorporateNonSegmentMember 2019-01-01 2019-06-30 0000928054 us-gaap:CorporateNonSegmentMember 2018-01-01 2018-06-30 0000928054 ftk:CustomerMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-06-30 0000928054 ftk:CustomerMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2019-04-01 2019-06-30 0000928054 ftk:CustomerBMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-06-30 0000928054 ftk:CustomerCMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2019-01-01 2019-06-30 0000928054 ftk:CustomerMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2018-04-01 2018-06-30 0000928054 ftk:CustomerBMember us-gaap:SalesMember us-gaap:CustomerConcentrationRiskMember 2019-04-01 2019-06-30 0000928054 country:US 2019-04-01 2019-06-30 0000928054 country:US 2018-01-01 2018-06-30 0000928054 us-gaap:NonUsMember 2018-04-01 2018-06-30 0000928054 country:US 2018-04-01 2018-06-30 0000928054 country:US 2019-01-01 2019-06-30 0000928054 us-gaap:NonUsMember 2019-04-01 2019-06-30 0000928054 us-gaap:NonUsMember 2019-01-01 2019-06-30 0000928054 us-gaap:NonUsMember 2018-01-01 2018-06-30 0000928054 ftk:PunitiveLawsuitsFiledintheUnitedStatesDistrictCourtfortheSouthernDistrictofTexasMember 2017-03-30 2017-03-30 0000928054 ftk:IRSTaxIndemnificationMember 2019-06-30 0000928054 ftk:IRSTaxIndemnificationMember srt:ChiefExecutiveOfficerMember 2019-06-30 iso4217:USD xbrli:shares xbrli:pure ftk:country iso4217:USD xbrli:shares ftk:lawsuit ftk:segment ftk:series
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM | 10-Q

☒ | QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2019
or

☐ | TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to
Commission File Number 1-13270

FLOTEK INDUSTRIES, INC.
(Exact name of registrant as specified in its charter)

Delaware |  | 90-0023731
(State of other jurisdiction of incorporation or organization) |  | (I.R.S. Employer Identification No.)
10603 W. Sam Houston Parkway N. | Suite 300 | Houston, | TX | 77064
(Address of principal executive offices) | (Zip Code)

(713) 849-9911
(Registrant’s telephone number, including area code)

Securities registered pursuant to Section 12(b) of the Act:
Title of each class | Trading Symbol(s) | Name of each exchange on which registered
Common Stock, $0.0001 par value | FTK | New York Stock Exchange

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐
Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer |  | ☐ |  | Accelerated Filer |  | ☒
Non-accelerated filer |  | ☐ |  | Smaller reporting company |  | ☒
|  |  |  | Emerging growth company |  | ☐

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No ☒
As of July 31, 2019, there were 57,697,905 outstanding shares of Flotek Industries, Inc. common stock, $0.0001 par value.

TABLE OF CONTENTS

PART I—FINANCIAL INFORMATION |
Item 1. | Financial Statements | 3
| Unaudited Condensed Consolidated Balance Sheets at June 30, 2019 and December 31, 2018 | 3
| Unaudited Condensed Consolidated Statements of Operations for the three and six months ended June 30, 2019 and 2018 | 4
| Unaudited Condensed Consolidated Statements of Comprehensive Income for the three and six months ended June 30, 2019 and 2018 | 5
| Unaudited Condensed Consolidated Statements of Cash Flows for the six months ended June 30, 2019 and 2018 | 6
| Unaudited Condensed Consolidated Statement of Stockholders’ Equity for the three and six months ended June 30, 2019 | 7
| Notes to Unaudited Condensed Consolidated Financial Statements | 9
Item 2. | Management’s Discussion and Analysis of Financial Condition and Results of Operations | 22
Item 3. | Quantitative and Qualitative Disclosures about Market Risk | 30
Item 4. | Controls and Procedures | 30
PART II—OTHER INFORMATION |
Item 1. | Legal Proceedings | 31
Item 1A. | Risk Factors | 31
Item 2. | Unregistered Sales of Equity Securities and Use of Proceeds | 32
Item 3. | Defaults Upon Senior Securities | 32
Item 4. | Mine Safety Disclosures | 32
Item 5. | Other Information | 32
Item 6. | Exhibits | 33
SIGNATURES | 34

2

PART I — FINANCIAL INFORMATION
Item 1. Financial Statements
FLOTEK INDUSTRIES, INC.
UNAUDITED CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except share data)

| June 30, 2019 |  | December 31, 2018
ASSETS |  |  |
Current assets: |  |  |
Cash and cash equivalents | $ | 97,509 |  |  | $ | 3,044 |
Restricted cash | 661 |  |  | — |
Accounts receivable, net of allowance for doubtful accounts of $1,676 and $1,190 at June 30, 2019 and December 31, 2018, respectively | 30,694 |  |  | 37,047 |
Inventories, net | 26,442 |  |  | 27,289 |
Income taxes receivable | 3,467 |  |  | 3,161 |
Assets held for sale | — |  |  | 118,470 |
Other current assets | 20,406 |  |  | 5,771 |
Total current assets | 179,179 |  |  | 194,782 |
Property and equipment, net | 41,760 |  |  | 45,485 |
Operating lease right-of-use assets | 17,982 |  |  | — |
Deferred tax assets, net | 605 |  |  | 18,663 |
Other intangible assets, net | 24,290 |  |  | 26,827 |
Other long-term assets | — |  |  | 126 |
TOTAL ASSETS | $ | 263,816 |  |  | $ | 285,883 |
LIABILITIES AND STOCKHOLDERS’ EQUITY |  |  |
Current liabilities: |  |  |
Accounts payable | $ | 10,858 |  |  | $ | 15,011 |
Accrued liabilities | 11,141 |  |  | 10,335 |
Income taxes payable | 862 |  |  | — |
Interest payable | — |  |  | 8 |
Liabilities held for sale | — |  |  | 9,174 |
Current portion of lease liabilities | 714 |  |  | — |
Long-term debt, classified as current | — |  |  | 49,731 |
Total current liabilities | 23,575 |  |  | 84,259 |
Long-term operating lease liabilities | 18,256 |  |  | — |
Long-term finance lease liabilities | 193 |  |  | — |
Deferred tax liabilities, net | 116 |  |  | — |
Total liabilities | 42,140 |  |  | 84,259 |
Commitments and contingencies |  |  |
Stockholders’ equity: |  |  |
Preferred stock, $0.0001 par value, 100,000 shares authorized; no shares issued and outstanding | — |  |  | — |
Common stock, $0.0001 par value, 80,000,000 shares authorized; 62,955,872 shares issued and 57,688,578 shares outstanding at June 30, 2019; 62,162,875 shares issued and 57,342,279 shares outstanding at December 31, 2018 | 6 |  |  | 6 |
Additional paid-in capital | 345,217 |  |  | 343,536 |
Accumulated other comprehensive loss | (998 | ) |  | (1,116 | )
Retained earnings (accumulated deficit) | (89,171 | ) |  | (107,565 | )
Treasury stock, at cost; 3,947,982 and 3,770,224 shares at June 30, 2019 and December 31, 2018, respectively | (33,378 | ) |  | (33,237 | )
Total stockholders’ equity | 221,676 |  |  | 201,624 |
TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $ | 263,816 |  |  | $ | 285,883 |

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.
3

FLOTEK INDUSTRIES, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)

| Three months ended June 30, |  | Six months ended June 30,
| 2019 |  | 2018 |  | 2019 |  | 2018
Revenue | $ | 34,692 |  |  | $ | 39,546 |  |  | $ | 77,949 |  |  | $ | 80,615 |
Costs and expenses: |  |  |  |  |  |  |
Operating expenses (excluding depreciation and amortization) | 38,306 |  |  | 35,544 |  |  | 82,904 |  |  | 72,199 |
Corporate general and administrative | 6,054 |  |  | 8,665 |  |  | 13,335 |  |  | 17,158 |
Depreciation and amortization | 2,119 |  |  | 2,343 |  |  | 4,379 |  |  | 4,676 |
Research and development | 2,076 |  |  | 2,949 |  |  | 4,360 |  |  | 5,704 |
(Gain)/loss on disposal of long-lived assets | (4 | ) |  | 5 |  |  | 1,093 |  |  | 62 |
Impairment of goodwill | — |  |  | 37,180 |  |  | — |  |  | 37,180 |
Total costs and expenses | 48,551 |  |  | 86,686 |  |  | 106,071 |  |  | 136,979 |
Loss from operations | (13,859 | ) |  | (47,140 | ) |  | (28,122 | ) |  | (56,364 | )
Other (expense) income: |  |  |  |  |  |  |
Interest expense | (16 | ) |  | (640 | ) |  | (2,014 | ) |  | (1,156 | )
Loss on write-down of assets held for sale | — |  |  | (2,580 | ) |  | — |  |  | (2,580 | )
Other income (expense), net | 693 |  |  | (2,499 | ) |  | 800 |  |  | (2,609 | )
Total other income (expense) | 677 |  |  | (5,719 | ) |  | (1,214 | ) |  | (6,345 | )
Loss before income taxes | (13,182 | ) |  | (52,859 | ) |  | (29,336 | ) |  | (62,709 | )
Income tax benefit (expense) | 192 |  |  | (16,128 | ) |  | 966 |  |  | (15,807 | )
Loss from continuing operations | (12,990 | ) |  | (68,987 | ) |  | (28,370 | ) |  | (78,516 | )
Income (loss) from discontinued operations, net of tax | (1,608 | ) |  | (6,404 | ) |  | 46,764 |  |  | 3,192 |
Net income (loss) | $ | (14,598 | ) |  | $ | (75,391 | ) |  | 18,394 |  |  | (75,324 | )
Net income attributable to noncontrolling interests | — |  |  | 357 |  |  | — |  |  | 357 |
Net income (loss) attributable to Flotek Industries, Inc. (Flotek) | $ | (14,598 | ) |  | $ | (75,034 | ) |  | $ | 18,394 |  |  | $ | (74,967 | )
Amounts attributable to Flotek shareholders: |  |  |  |  |  |  |
Loss from continuing operations | $ | (12,990 | ) |  | $ | (68,630 | ) |  | $ | (28,370 | ) |  | $ | (78,159 | )
Income (loss) from discontinued operations, net of tax | (1,608 | ) |  | (6,404 | ) |  | 46,764 |  |  | 3,192 |
Net income (loss) attributable to Flotek | $ | (14,598 | ) |  | $ | (75,034 | ) |  | $ | 18,394 |  |  | $ | (74,967 | )
Basic earnings (loss) per common share: |  |  |  |  |  |
Continuing operations | $ | (0.22 | ) |  | $ | (1.19 | ) |  | $ | (0.49 | ) |  | $ | (1.36 | )
Discontinued operations, net of tax | (0.03 | ) |  | (0.11 | ) |  | 0.80 |  |  | 0.06 |
Basic earnings (loss) per common share | $ | (0.25 | ) |  | $ | (1.30 | ) |  | $ | 0.31 |  |  | $ | (1.30 | )
Diluted earnings (loss) per common share: |  |  |  |  |  |
Continuing operations | $ | (0.22 | ) |  | $ | (1.19 | ) |  | $ | (0.49 | ) |  | $ | (1.36 | )
Discontinued operations, net of tax | (0.03 | ) |  | (0.11 | ) |  | 0.80 |  |  | 0.06 |
Diluted earnings (loss) per common share | $ | (0.25 | ) |  | $ | (1.30 | ) |  | $ | 0.31 |  |  | $ | (1.30 | )
Weighted average common shares: |  |  |  |  |  |  |
Weighted average common shares used in computing basic earnings (loss) per common share | 58,608 |  |  | 57,869 |  |  | 58,491 |  |  | 57,566 |
Weighted average common shares used in computing diluted earnings (loss) per common share | 58,608 |  |  | 57,869 |  |  | 58,491 |  |  | 57,566 |

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.
4

FLOTEK INDUSTRIES, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(in thousands)

| Three months ended June 30, |  | Six months ended June 30,
| 2019 |  | 2018 |  | 2019 |  | 2018
Loss from continuing operations | $ | (12,990 | ) |  | $ | (68,987 | ) |  | $ | (28,370 | ) |  | $ | (78,516 | )
Income (loss) from discontinued operations, net of tax | (1,608 | ) |  | (6,404 | ) |  | 46,764 |  |  | 3,192 |
Net income (loss) | (14,598 | ) |  | (75,391 | ) |  | 18,394 |  |  | (75,324 | )
Other comprehensive income (loss): |  |  |  |  |  |  |
Foreign currency translation adjustment | 24 |  |  | 18 |  |  | 118 |  |  | (161 | )
Comprehensive income (loss) | $ | (14,574 | ) |  | $ | (75,373 | ) |  | 18,512 |  |  | (75,485 | )
Net loss attributable to noncontrolling interests | — |  |  | 357 |  |  | — |  |  | 357 |
Comprehensive income (loss) attributable to Flotek | $ | (14,574 | ) |  | $ | (75,016 | ) |  | $ | 18,512 |  |  | $ | (75,128 | )

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.
5

FLOTEK INDUSTRIES, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)

| Six months ended June 30,
| 2019 |  | 2018
Cash flows from operating activities: |  |  |
Net income (loss) attributable to Flotek Industries, Inc. (Flotek) | $ | 18,394 |  |  | $ | (74,967 | )
Income from discontinued operations, net of tax | 46,764 |  |  | 3,192 |
Loss from continuing operations | (28,370 | ) |  | (78,159 | )
Adjustments to reconcile loss from continuing operations to net cash used in operating activities: |  |  |
Depreciation and amortization | 4,379 |  |  | 4,676 |
Amortization of deferred financing costs | 1,428 |  |  | 192 |
Provision for doubtful accounts | 102 |  |  | (471 | )
Provision for excess and obsolete inventory | — |  |  | 1,942 |
Impairment of goodwill | — |  |  | 37,180 |
Loss on write-down of assets held for sale | — |  |  | 2,580 |
Loss on disposal of long-lived assets | 1,093 |  |  | 62 |
Non-cash lease expense | 464 |  |  | — |
Stock compensation expense | 1,669 |  |  | 4,385 |
Deferred income tax provision | 17,855 |  |  | 15,459 |
Reduction in tax benefit related to share-based awards | 24 |  |  | 72 |
Changes in current assets and liabilities: |  |  |
Restricted cash | (661 | ) |  | — |
Accounts receivable, net | 6,289 |  |  | 5,881 |
Inventories, net | 907 |  |  | (2,080 | )
Income taxes receivable | (281 | ) |  | 63 |
Other current assets | (16,209 | ) |  | 1,151 |
Accounts payable | (4,157 | ) |  | 4,325 |
Accrued liabilities | (10,216 | ) |  | (16,889 | )
Income taxes payable | 1,182 |  |  | — |
Interest payable | (8 | ) |  | (19 | )
Net cash used in operating activities | (24,510 | ) |  | (19,650 | )
Cash flows from investing activities: |  |  |
Capital expenditures | (767 | ) |  | (2,631 | )
Proceeds from sales of business | 169,722 |  |  | — |
Proceeds from sale of assets | 140 |  |  | 90 |
Purchase of patents and other intangible assets | (227 | ) |  | (181 | )
Net cash provided by (used in) investing activities | 168,868 |  |  | (2,722 | )
Cash flows from financing activities: |  |  |
Borrowings on revolving credit facility | 42,984 |  |  | 146,038 |
Repayments on revolving credit facility | (92,715 | ) |  | (124,862 | )
Debt issuance costs | — |  |  | (98 | )
Purchase of treasury stock related to share-based awards | (142 | ) |  | (24 | )
Proceeds from sale of common stock | — |  |  | 247 |
Payments for finance leases | (38 | ) |  | — |
Loss from noncontrolling interest | — |  |  | (357 | )
Net cash (used in) provided by financing activities | (49,911 | ) |  | 20,944 |
Discontinued operations: |  |  |
Net cash (used in) provided by operating activities | (321 | ) |  | 644 |
Net cash provided by (used in) investing activities | 337 |  |  | (630 | )
Net cash flows provided by discontinued operations | 16 |  |  | 14 |
Effect of changes in exchange rates on cash and cash equivalents | 2 |  |  | (74 | )
Net increase (decrease) in cash and cash equivalents | 94,465 |  |  | (1,488 | )
Cash and cash equivalents at the beginning of period | 3,044 |  |  | 4,584 |
Cash and cash equivalents at the end of period | $ | 97,509 |  |  | $ | 3,096 |

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.
6

FLOTEK INDUSTRIES, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY
(in thousands)

| Three months ended June 30, 2019
| Common Stock |  | Treasury Stock |  | Additional Paid-in Capital |  | Accumulated Other Comprehensive Income (Loss) |  | Retained Earnings (Accumulated Deficit) |  | Non-controlling Interests |  | Total Stockholders’ Equity
| Shares Issued |  | Par Value |  | Shares |  | Cost |
Balance, March 31, 2019 | 62,199 |  |  | $ | 6 |  |  | 3,845 |  |  | $ | (33,368 | ) |  | $ | 344,004 |  |  | $ | (1,022 | ) |  | $ | (74,573 | ) |  | $ | — |  |  | $ | 235,047 |
Net income | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (14,598 | ) |  | — |  |  | (14,598 | )
Foreign currency translation adjustment | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 24 |  |  | — |  |  | — |  |  | 24 |
Restricted stock granted | 757 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Restricted stock forfeited | — |  |  | — |  |  | 99 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Treasury stock purchased | — |  |  | — |  |  | 4 |  |  | (10 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (10 | )
Stock compensation expense | — |  |  | — |  |  | — |  |  | — |  |  | 1,213 |  |  | — |  |  | — |  |  | — |  |  | 1,213 |
Balance, June 30, 2019 | 62,956 |  |  | $ | 6 |  |  | 3,948 |  |  | $ | (33,378 | ) |  | $ | 345,217 |  |  | $ | (998 | ) |  | $ | (89,171 | ) |  | $ | — |  |  | $ | 221,676 |

| Three months ended June 30, 2018
| Common Stock |  | Treasury Stock |  | Additional Paid-in Capital |  | Accumulated Other Comprehensive Income (Loss) |  | Retained Earnings (Accumulated Deficit) |  | Non-controlling Interests |  | Total Stockholders’ Equity
| Shares Issued |  | Par Value |  | Shares |  | Cost |
Balance, March 31, 2018 | 61,161 |  |  | $ | 6 |  |  | 3,599 |  |  | $ | (33,067 | ) |  | $ | 338,137 |  |  | $ | (1,063 | ) |  | $ | (37,158 | ) |  | $ | 358 |  |  | $ | 267,213 |
Net loss | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (75,034 | ) |  | (357 | ) |  | (75,391 | )
Foreign currency translation adjustment | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 18 |  |  | — |  |  | — |  |  | 18 |
Stock issued under employee stock purchase plan | — |  |  | — |  |  | (36 | ) |  | — |  |  | 100 |  |  | — |  |  | — |  |  | — |  |  | 100 |
Restricted stock granted | 481 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Restricted stock forfeited | — |  |  | — |  |  | 39 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Treasury stock purchased | — |  |  | — |  |  | 5 |  |  | (21 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (21 | )
Stock compensation expense | — |  |  | — |  |  | — |  |  | — |  |  | 2,381 |  |  | — |  |  | — |  |  | — |  |  | 2,381 |
Balance, June 30, 2018 | 61,642 |  |  | $ | 6 |  |  | 3,607 |  |  | $ | (33,088 | ) |  | $ | 340,618 |  |  | $ | (1,045 | ) |  | $ | (112,192 | ) |  | $ | 1 |  |  | $ | 194,300 |

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.
7

FLOTEK INDUSTRIES, INC.
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (continued)
(in thousands)

| Six months ended June 30, 2019
| Common Stock |  | Treasury Stock |  | Additional Paid-in Capital |  | Accumulated Other Comprehensive Income (Loss) |  | Retained Earnings (Accumulated Deficit) |  | Non-controlling Interests |  | Total Stockholders’ Equity
| Shares Issued |  | Par Value |  | Shares |  | Cost |
Balance, December 31, 2018 | 62,163 |  |  | $ | 6 |  |  | 3,770 |  |  | $ | (33,237 | ) |  | $ | 343,536 |  |  | $ | (1,116 | ) |  | $ | (107,565 | ) |  | $ | — |  |  | $ | 201,624 |
Net income | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 18,394 |  |  | — |  |  | 18,394 |
Foreign currency translation adjustment | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | 118 |  |  | — |  |  | — |  |  | 118 |
Restricted stock granted | 793 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Restricted stock forfeited | — |  |  | — |  |  | 133 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Treasury stock purchased | — |  |  | — |  |  | 45 |  |  | (141 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (141 | )
Stock compensation expense | — |  |  | — |  |  | — |  |  | — |  |  | 1,681 |  |  | — |  |  | — |  |  | — |  |  | 1,681 |
Balance, June 30, 2019 | 62,956 |  |  | $ | 6 |  |  | 3,948 |  |  | $ | (33,378 | ) |  | $ | 345,217 |  |  | $ | (998 | ) |  | $ | (89,171 | ) |  | $ | — |  |  | $ | 221,676 |

| Six months ended June 30, 2018
| Common Stock |  | Treasury Stock |  | Additional Paid-in Capital |  | Accumulated Other Comprehensive Income (Loss) |  | Retained Earnings (Accumulated Deficit) |  | Non-controlling Interests |  | Total Stockholders’ Equity
| Shares Issued |  | Par Value |  | Shares |  | Cost |
Balance, December 31, 2017 | 60,623 |  |  | $ | 6 |  |  | 3,621 |  |  | $ | (33,064 | ) |  | $ | 336,067 |  |  | $ | (884 | ) |  | $ | (37,225 | ) |  | $ | 358 |  |  | $ | 265,258 |
Net loss | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (74,967 | ) |  | (357 | ) |  | (75,324 | )
Foreign currency translation adjustment | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | (161 | ) |  | — |  |  | — |  |  | (161 | )
Stock issued under employee stock purchase plan | — |  |  | — |  |  | (65 | ) |  | — |  |  | 247 |  |  | — |  |  | — |  |  | — |  |  | 247 |
Restricted stock granted | 1,019 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Restricted stock forfeited | — |  |  | — |  |  | 45 |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |  |  | — |
Treasury stock purchased | — |  |  | — |  |  | 6 |  |  | (24 | ) |  | — |  |  | — |  |  | — |  |  | — |  |  | (24 | )
Stock compensation expense | — |  |  | — |  |  | — |  |  | — |  |  | 4,304 |  |  | — |  |  | — |  |  | — |  |  | 4,304 |
Balance, June 30, 2018 | 61,642 |  |  | $ | 6 |  |  | 3,607 |  |  | $ | (33,088 | ) |  | $ | 340,618 |  |  | $ | (1,045 | ) |  | $ | (112,192 | ) |  | $ | 1 |  |  | $ | 194,300 |

See accompanying Notes to Unaudited Condensed Consolidated Financial Statements.
8

FLOTEK INDUSTRIES, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Note 1 — Organization and Significant Accounting Policies
Organization and Nature of Operations
Flotek Industries, Inc. (“Flotek” or the “Company”) is an international energy chemistry technology-driven company that develops and supplies chemistry and services to the oil and gas industry. Flotek also supplied high value compounds to companies that make food and beverages, cleaning products, cosmetics, and other products that are sold in consumer and industrial markets, classified as discontinued operations at December 31, 2018.
The Company’s oilfield business includes specialty chemistries and logistics which enable its customers to pursue improved efficiencies in the drilling and completion of their wells. The Company also provides automated bulk material handling, loading facilities, and blending capabilities. In the segment reported as discontinued operations at December 31, 2018, the Company processed citrus oil to produce (1) high value compounds used as additives by companies in the flavors and fragrances markets and (2) environmentally friendly chemistries for use in numerous industries around the world, including the oil and gas (“O&G”) industry.
Flotek operates in over 15 domestic and international markets. Customers include major integrated O&G companies, oilfield services companies, independent O&G companies, pressure-pumping service companies, national and state-owned oil companies, and international supply chain management companies. The Company also served customers who purchase non-energy-related citrus oil and related products, including household and commercial cleaning product companies, fragrance and cosmetic companies, and food manufacturing companies, reported as discontinued operations at December 31, 2018.
Flotek was initially incorporated under the laws of the Province of British Columbia on May 17, 1985. On October 23, 2001, Flotek changed its corporate domicile to the state of Delaware.
Basis of Presentation
The accompanying Unaudited Condensed Consolidated Financial Statements and accompanying footnotes (collectively the “Financial Statements”) reflect all adjustments, in the opinion of management, necessary for fair presentation of the financial condition and results of operations for the periods presented. All such adjustments are normal and recurring in nature. The Financial Statements, including selected notes, have been prepared in accordance with applicable rules and regulations of the Securities and Exchange Commission (“SEC”) regarding interim financial reporting and do not include all information and disclosures required by accounting principles generally accepted in the United States of America (“U.S. GAAP”) for comprehensive financial statement reporting. These interim Financial Statements should be read in conjunction with the audited consolidated financial statements and notes included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2018 (“Annual Report”). A copy of the Annual Report is available on the SEC’s website, www.sec.gov, under the Company’s ticker symbol (“FTK”) or on Flotek’s website, www.flotekind.com. The results of operations for the three and six months ended June 30, 2019 are not necessarily indicative of the results to be expected for the year ended December 31, 2019.
During the fourth quarter of 2018, the Company classified the Consumer and Industrial Chemistry Technologies segment as held for sale based on management’s intention to sell this business. The Company’s historical financial statements have been revised to present the operating results of the Consumer and Industrial Chemistry Technologies segment as discontinued operations. The results of operations of this segment are presented as “Income (loss) from discontinued operations” in the statement of operations and the related cash flows of this segment have been reclassified to discontinued operations for all periods presented. The assets and liabilities of the Consumer and Industrial Chemistry Technologies segment have been reclassified to “Assets held for sale” and “Liabilities held for sale”, respectively, in the consolidated balance sheet for all periods presented.
All significant intercompany accounts and transactions have been eliminated in consolidation. The Company does not have investments in any unconsolidated subsidiaries.
Leases
The Company determines if an arrangement is a lease at inception. Operating leases are included in operating lease right-of-use (“ROU”) assets, current portion of lease liabilities, and operating lease liabilities in the consolidated balance sheets. Finance leases are included in property and equipment, current portion of lease liabilities, and finance lease liabilities in the consolidated balance sheets.
ROU assets represent the Company’s right to use an underlying asset for the lease term and lease liabilities represent the Company’s obligation to make lease payments arising from the lease. Operating lease ROU assets and liabilities are recognized at the
9

FLOTEK INDUSTRIES, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
commencement date based on the present value of lease payments over the lease term. As the leases do not provide an implicit rate, the Company uses its incremental borrowing rate based on the information available at the commencement date in determining the present value of lease payments. The Company uses the implicit rate when readily determinable. The lease term is modified to reflect options to extend or terminate the lease when it is reasonably certain the Company will exercise that option. Lease expense for lease payments is recognized on a straight-line basis over the lease term.
The Company has some lease agreements that contain both lease and non-lease components. The Company has elected to account for such leases as having a single lease component.
Use of Estimates
The preparation of financial statements in conformity with U.S. GAAP requires management to make estimates and assumptions that affect reported amounts of assets and liabilities, disclosure of contingent assets and liabilities, and reported amounts of revenue and expenses. Actual results could differ from these estimates.
Reclassifications
Certain prior period amounts have been reclassified to conform to the current period presentation. The reclassifications did not impact net loss.
Note 2 — Recent Accounting Pronouncements
Application of New Accounting Standards
Effective January 1, 2019, the Company adopted the accounting guidance in Accounting Standards Update (“ASU”) No. 2016-02, “Leases.” This standard (ASC 842) requires the recognition of ROU assets and lease liabilities by lessees for those leases classified as operating leases under previous U.S. GAAP (ASC 840). The Company adopted ASC 842 using the optional transition method. Consequently, the Company’s reporting for the comparative periods presented prior to 2019 in the financial statements will continue to be in accordance with ASC 840. Upon adoption, the Company recorded operating lease ROU assets and corresponding operating lease liabilities, net of deferred rent, of approximately $18.4 million, representing the present value of future lease payments under operating leases with terms of greater than twelve months. The adoption of this standard did not have a material impact on the consolidated statements of operations or cash flows. Refer to Note 4 — “Leases” for further information surrounding adoption of this new standard.
Effective January 1, 2019, the Company adopted ASU No. 2018-02, “Reclassification of Certain Tax Effects from Accumulated Other Comprehensive Income.” This standard allows a reclassification from accumulated other comprehensive income to retained earnings for stranded tax effects resulting from the 2017 Tax Cuts and Jobs Act. Implementation of this standard did not have a material effect on the consolidated financial statements and related disclosures.
Effective January 1, 2019, the Company adopted ASU No. 2018-07, “Improvements to Nonemployee Share-Based Payment Accounting.” This standard expands the scope of Topic 718 to include share-based payment transactions for acquiring goods and services from nonemployees. Implementation of this standard did not have a material effect on the consolidated financial statements and related disclosures.
New Accounting Requirements and Disclosures
In June 2016, the FASB issued ASU No. 2016-13, “Measurement of Credit Losses on Financial Instruments.” This standard replaces the incurred loss impairment methodology in current U.S. GAAP with a methodology that reflects expected credit losses and requires consideration of a broader range of reasonable and supportable information to inform credit loss estimates. The pronouncement is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, with early adoption for the fiscal years beginning after December 15, 2018, including interim periods within those fiscal years. The Company is currently evaluating the impact the pronouncement will have on the consolidated financial statements and related disclosures.
In August 2018, the FASB issued ASU No. 2018-13, “Disclosure Framework — Changes to the Disclosure Requirements for Fair Value Measurement.” This standard removes, modifies, and adds additional requirements for disclosures related to fair value measurement in ASC 820. The pronouncement is effective for fiscal years beginning after December 15, 2019, including interim periods within those fiscal years, with early adoption permitted in any interim period. The Company is currently evaluating the impact the pronouncement will have on the consolidated financial statements and related disclosures.
10

FLOTEK INDUSTRIES, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Note 3 — Discontinued Operations
During the fourth quarter of 2018, the Company initiated and began executing a strategic plan to sell its Consumer and Industrial Chemistry Technologies (“CICT”) segment. An investment banking advisory services firm was engaged and actively marketed this segment.
The Company met all of the criteria to classify the CICT segment’s assets and liabilities as held for sale in the fourth quarter 2018. The Company has classified the assets, liabilities, and results of operations for this segment as “Discontinued Operations” for all periods presented.
Disposal of the CICT reporting segment represented a strategic shift that will have a major effect on the Company’s operations and financial results.
On January 10, 2019, the Company entered into a Share Purchase Agreement with Archer-Daniels-Midland Company (“ADM”) for the sale of all of the shares representing membership interests in its wholly owned subsidiary, Florida Chemical Company, LLC, which represented the CICT segment.
Effective February 28, 2019, the Company completed the sale of the CICT segment to ADM for $175.0 million in cash consideration, with $4.4 million temporarily held in escrow by ADM for post-closing working capital adjustments for up to 90 days and $13.1 million temporarily held in escrow to satisfy potential indemnification claims by ADM with anticipated releases at 6 months, 12 months, and 15 months.
As of June 30, 2019, the Company and ADM had not reached an agreement on the post-closing working capital adjustment. As of this filing, the Company is in process of engaging a third party to assist with reaching a conclusion.
Concurrent with the closing of the sale of the CICT segment, the Company retained $11.1 million of historical inventory previously held by the CICT segment. In addition, the Company executed a long-term supply agreement for terpene product, which serves as a feedstock to some of the Company’s key value-added products. The term of the agreement runs through September 2023, with an option to extend for an additional year. This agreement secures the Company’s access to a sufficient supply of terpene and includes a minimum annual purchase requirement at variable prices during the term of the agreement.
The following summarized financial information has been segregated from continuing operations and reported as Discontinued Operations for the three and six months ended June 30, 2019 and 2018 (in thousands):

| Three months ended June 30, |  | Six months ended June 30,
| 2019 |  | 2018 |  | 2019 |  | 2018
Consumer and Industrial Chemistry Technologies |  |  |  |  |  |  |
Revenue | $ | — |  |  | $ | 19,540 |  |  | $ | 11,031 |  |  | $ | 38,987 |
Operating expenses | — |  |  | (18,066 | ) |  | (11,572 | ) |  | (34,236 | )
Depreciation and amortization | — |  |  | (682 | ) |  | — |  |  | (1,351 | )
Research and development | — |  |  | (153 | ) |  | (69 | ) |  | (322 | )
(Loss) income from operations | — |  |  | 639 |  |  | (610 | ) |  | 3,078 |
Other income | — |  |  | 366 |  |  | 35 |  |  | 192 |
Gain (Loss) on sale of business | (2,100 | ) |  | — |  |  | 67,694 |  |  | — |
(Loss) income before income taxes | (2,100 | ) |  | 1,005 |  |  | 67,119 |  |  | 3,270 |
Income tax benefit (expense) | 492 |  |  | (7,409 | ) |  | (20,355 | ) |  | (78 | )
Net income (loss) from discontinued operations | $ | (1,608 | ) |  | $ | (6,404 | ) |  | $ | 46,764 |  |  | $ | 3,192 |

11

FLOTEK INDUSTRIES, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
The assets and liabilities held for sale on the Consolidated Balance Sheets as of June 30, 2019 and December 31, 2018, are as follows (in thousands):

| Consumer and Industrial Chemistry Technologies
| June 30, 2019 |  | December 31, 2018
Assets: |  |  |
Accounts receivable, net | $ | — |  |  | $ | 10,547 |
Inventories, net | — |  |  | 52,069 |
Other current assets | — |  |  | 446 |
Property and equipment, net | — |  |  | 15,899 |
Goodwill | — |  |  | 19,480 |
Other intangible assets, net | — |  |  | 20,029 |
Assets held for sale | — |  |  | 118,470 |
Valuation allowance | — |  |  | — |
Assets held for sale, net | $ | — |  |  | $ | 118,470 |
Liabilities: |  |  |
Accounts payable | $ | — |  |  | $ | 8,883 |
Accrued liabilities | — |  |  | 291 |
Liabilities held for sale | $ | — |  |  | $ | 9,174 |

Note 4 — Leases
Effective January 1, 2019, the Company adopted ASC 842 using the prospective method applied to those leases which were not completed as of December 31, 2018. The Company has leases for corporate offices, research and development facilities, warehouses, sales offices and equipment. The leases have remaining lease terms of 1 year to 19 years, some of which include options to extend the leases for up to 10 years.
Upon adoption, the Company recorded operating lease ROU assets and corresponding operating lease liabilities, net of deferred rent, of approximately $18.4 million, representing the present value of future lease payments under operating leases with terms of greater than twelve months. Leases with an initial expected term of 12 months or less are not recorded on the balance sheet. The Company recognizes lease expense for these leases on a straight-line basis over the expected lease term.
The components of lease expense and supplemental cash flow information are as follows (in thousands):

| Three months ended June 30, 2019 |  | Six months ended June 30, 2019
Operating lease expense | $ | 653 |  |  | $ | 1,306 |
Finance lease expense: |  |  |
Amortization of right-of-use assets | 220 |  |  | 220 |
Interest on lease liabilities | 3 |  |  | 3 |
Total finance lease expense | 223 |  |  | 223 |
Short-term lease expense | 32 |  |  | 75 |
Total lease expense | $ | 908 |  |  | $ | 1,604 |
Cash paid for amounts included in the measurement of lease liabilities: |  |  |
Operating cash flows from operating leases | $ | 583 |  |  | $ | 1,165 |
Operating cash flows from finance leases | 3 |  |  | 3 |
Financing cash flows from finance leases | 38 |  |  | 38 |

12

FLOTEK INDUSTRIES, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Maturities of lease liabilities are as follows (in thousands):

Year ending December 31, |  | Operating Leases |  | Finance Leases
2019 (excluding the three months ended June 30, 2019) | $ | 1,174 |  |  | $ | 20 |
2020 |  | 2,348 |  |  | 71 |
2021 |  | 2,307 |  |  | 71 |
2022 |  | 2,270 |  |  | 39 |
2023 |  | 2,180 |  |  | 39 |
Thereafter |  | 25,877 |  |  | 23 |
Total lease payments |  | $ | 36,156 |  |  | $ | 263 |
Less: Interest |  | (17,213 | ) |  | (43 | )
Present value of lease liabilities |  | $ | 18,943 |  |  | $ | 220 |

Supplemental balance sheet information related to leases is as follows (in thousands):

| June 30, 2019
Operating Leases |
Operating lease right-of-use assets | $ | 17,982 |
Current portion of lease liabilities | $ | 687 |
Long-term operating lease liabilities | 18,256 |
Total operating lease liabilities | $ | 18,943 |
Finance Leases |
Property and equipment | $ | 297 |
Accumulated depreciation | (10 | )
Property and equipment, net | $ | 287 |
Current portion of lease liabilities | $ | 27 |
Long-term finance lease liabilities | 193 |
Total finance lease liabilities | $ | 220 |
Weighted Average Remaining Lease Term |
Operating leases | 15.8 years |
Finance leases | 5.1 years |
Weighted Average Discount Rate |
Operating leases | 8.9 | %
Finance leases | 8.5 | %

Note 5 — Revenue from Contracts with Customers
Revenues are recognized when control of the promised goods or services is transferred to the customer, in an amount that reflects the consideration the Company expects to be entitled to in exchange for those goods or services. In recognizing revenue for products and services, the Company determines the transaction price of purchase orders or contracts with customers, which may consist of fixed and variable consideration. Determining the transaction price may require significant judgment by management, which includes identifying performance obligations, estimating variable consideration to include in the transaction price, and determining whether promised goods or services are distinct within the context of the contract. Variable consideration typically consists of product returns and is estimated based on the amount of consideration the Company expects to receive. Revenue accruals are recorded on an ongoing basis to reflect updated variable consideration information.
13

FLOTEK INDUSTRIES, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
For certain contracts, the Company recognizes revenue under the percentage-of-completion method of accounting, measured by the percentage of “costs incurred to date” to the “total estimated costs of completion.” This percentage is applied to the “total estimated revenue at completion” to calculate proportionate revenue earned to date. For the three and six months ended June 30, 2019 and 2018, the percentage-of-completion revenue accounted for less than 0.1% of total revenue during the respective time periods. This resulted in immaterial unfulfilled performance obligations and immaterial contract assets and/or liabilities, for which the Company did not record adjustments to opening retained earnings as of December 31, 2015 or for any periods previously presented.
The vast majority of the Company’s products are sold at a point in time and service contracts are short-term in nature. Sales are billed on a monthly basis with payment terms customarily 30 days from invoice receipt. In addition, sales taxes are excluded from revenues.
Disaggregation of Revenue
The Company has disaggregated revenues by product sales (point-in-time revenue recognition) and service revenue (over-time revenue recognition), where product sales accounted for over 95% of total revenue for the three and six months ended June 30, 2019 and 2018.
The Company differentiates revenue and operating expenses (excluding depreciation and amortization) based on whether the source of revenue is attributable to products or services. Revenue and operating expenses (excluding depreciation and amortization) disaggregated by revenue source are as follows (in thousands):

| Three months ended June 30, |  | Six months ended June 30,
| 2019 |  | 2018 |  | 2019 |  | 2018
Revenue: |  |  |  |  |  |  |
Products | $ | 33,632 |  |  | $ | 38,213 |  |  | $ | 75,703 |  |  | $ | 78,142 |
Services | 1,060 |  |  | 1,333 |  |  | 2,246 |  |  | 2,473 |
| $ | 34,692 |  |  | $ | 39,546 |  |  | $ | 77,949 |  |  | $ | 80,615 |
Operating expenses (excluding depreciation and amortization): |  |  |  |  |  |
Products | $ | 37,798 |  |  | $ | 34,062 |  |  | $ | 81,877 |  |  | $ | 69,247 |
Services | 508 |  |  | 1,482 |  |  | 1,027 |  |  | 2,952 |
| $ | 38,306 |  |  | $ | 35,544 |  |  | $ | 82,904 |  |  | $ | 72,199 |

Arrangements with Multiple Performance Obligations
The Company’s contracts with customers may include multiple performance obligations. For such arrangements, the total transaction price is allocated to each performance obligation in an amount based on the estimated relative standalone selling prices of the promised goods or services underlying each performance obligation. Standalone selling prices are generally determined based on the prices charged to customers (“observable standalone price”) or an expected cost plus a margin approach. For combined products and services within a contract, the Company accounts for individual products and services separately if they are distinct (i.e. if a product or service is separately identifiable from other items in the contract and if a customer can benefit from it on its own or with other resources that are readily available to the customer). The consideration is allocated between separate products and services within a contract based on the prices at the observable standalone price. For items that are not sold separately, the expected cost plus a margin approach is used to estimate the standalone selling price of each performance obligation.
Contract Balances
Under revenue contracts for both products and services, customers are invoiced once the performance obligations have been satisfied, at which point payment is unconditional. Accordingly, no revenue contracts give rise to contract assets or liabilities under ASC 606.
14

FLOTEK INDUSTRIES, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Note 6 — Supplemental Cash Flow Information
Supplemental cash flow information is as follows (in thousands):

| Six months ended June 30,
| 2019 |  | 2018
Supplemental cash payment information: |  |  |
Interest paid | $ | 594 |  |  | $ | 983 |
Income taxes paid, net of refunds | 627 |  |  | 327 |

Note 7 — Inventories
Inventories are as follows (in thousands):

| June 30, 2019 |  | December 31, 2018
Raw materials | $ | 11,076 |  |  | $ | 10,608 |
Finished goods | 16,284 |  |  | 18,798 |
Inventories | 27,360 |  |  | 29,406 |
Less reserve for excess and obsolete inventory | (918 | ) |  | (2,117 | )
Inventories, net | $ | 26,442 |  |  | $ | 27,289 |

Note 8 — Property and Equipment
Property and equipment are as follows (in thousands):

| June 30, 2019 |  | December 31, 2018
Land | $ | 4,372 |  |  | $ | 4,372 |
Buildings and leasehold improvements | 37,787 |  |  | 37,719 |
Machinery and equipment | 26,802 |  |  | 26,995 |
Fixed assets in progress | 639 |  |  | 581 |
Furniture and fixtures | 1,733 |  |  | 1,573 |
Transportation equipment | 1,700 |  |  | 1,852 |
Computer equipment and software | 5,543 |  |  | 9,370 |
Property and equipment | 78,576 |  |  | 82,462 |
Less accumulated depreciation | (36,816 | ) |  | (36,977 | )
Property and equipment, net | $ | 41,760 |  |  | $ | 45,485 |

Depreciation expense totaled $1.6 million and $2.0 million for the three months ended June 30, 2019 and 2018, respectively, and $3.4 million and $4.0 million for the six months ended June 30, 2019 and 2018, respectively.
During the three and six months ended June 30, 2019 and 2018, no impairments were recognized related to property and equipment.
Note 9 — Goodwill
During the second quarter of 2018, the Company recognized a goodwill impairment charge of $37.2 million in the Energy Chemistry Technologies (“ECT”) reporting unit, which resulted from sustained under-performance and lower expectations related to the reporting unit. As a result of these factors, a qualitative analysis, and additional risks associated with the business, the Company concluded that sufficient indicators existed to require an interim quantitative assessment of goodwill for that reporting unit as of June 30, 2018. The fair value of the reporting unit was estimated based on an analysis of the present value of future discounted cash flows. The significant estimates used in the discounted cash flows model included the Company’s weighted average cost of capital, projected cash flows and the long-term rate of growth. The assumptions were based on the actual historical performance of the reporting unit and took into account a recent weakening of operating results in an improving market environment. The excess of the reporting unit’s carrying value over the estimated fair value was recorded as the goodwill impairment charge in the second quarter 2018 and represented all of the ECT reporting unit’s goodwill.
15

FLOTEK INDUSTRIES, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
The Company has no reporting units which had a goodwill balance at December 31, 2018, and there were no acquisitions during the three and six months ended June 30, 2019.
Note 10 — Other Intangible Assets
Other intangible assets are as follows (in thousands):

| June 30, 2019 |  | December 31, 2018
| Cost |  | Accumulated Amortization |  | Cost |  | Accumulated Amortization
Finite-lived intangible assets: |  |  |  |  |  |  |
Patents and technology | $ | 18,851 |  |  | $ | 7,270 |  |  | $ | 18,884 |  |  | $ | 6,689 |
Customer lists | 15,367 |  |  | 5,636 |  |  | 15,367 |  |  | 5,259 |
Trademarks and brand names | 1,358 |  |  | 1,140 |  |  | 1,485 |  |  | 1,149 |
Total finite-lived intangible assets acquired | 35,576 |  |  | 14,046 |  |  | 35,736 |  |  | 13,097 |
Deferred financing costs | — |  |  | — |  |  | 1,924 |  |  | 496 |
Total amortizable intangible assets | 35,576 |  |  | $ | 14,046 |  |  | 37,660 |  |  | $ | 13,593 |
Indefinite-lived intangible assets: |  |  |  |  |  |  |
Trademarks and brand names | 2,760 |  |  |  |  | 2,760 |  |  |
Total other intangible assets | $ | 38,336 |  |  |  |  | $ | 40,420 |  |  |
Carrying value: |  |  |  |  |  |  |
Other intangible assets, net | $ | 24,290 |  |  |  |  | $ | 26,827 |  |  |

Finite-lived intangible assets acquired are amortized on a straight-line basis over two to 20 years. Amortization of finite-lived intangible assets acquired totaled $0.5 million and $0.3 million for the three months ended June 30, 2019 and 2018, respectively, and $1.0 million and $0.7 million for the six months ended June 30, 2019 and 2018.
Amortization of deferred financing costs totaled zero and $0.1 million for the three months ended June 30, 2019 and 2018, respectively, and $1.4 million and 0.2 million for the six months ended June 30, 2019 and 2018.
Note 11 — Long-Term Debt and Credit Facility
Long-term debt is as follows (in thousands):

| June 30, 2019 |  | December 31, 2018
Long-term debt, classified as current: |  |  |
Borrowings under revolving credit facility | $ | — |  |  | $ | 49,731 |

Borrowing under the revolving credit agreement at December 31, 2018 was classified as current debt.
Credit Facility
On May 10, 2013, the Company and certain of its subsidiaries (the “Borrowers”) entered into an Amended and Restated Revolving Credit, Term Loan and Security Agreement (as amended, the “Credit Facility”) with PNC Bank, National Association (“PNC Bank”). The Company could borrow under the Credit Facility for working capital, permitted acquisitions, capital expenditures and other corporate purposes. The Credit Facility was to continue in effect until May 10, 2022. Under terms of the Credit Facility, the Company had total borrowing availability of $75 million under a revolving credit facility, including a sublimit of $10 million that could be used for letters of credit. On March 1, 2019, the Company repaid the outstanding balance, interest, and fees related to the revolving credit facility, and simultaneously terminated the Credit Facility.
16

FLOTEK INDUSTRIES, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Note 12 — Earnings (Loss) Per Share
Basic earnings (loss) per common share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding for the period. Diluted earnings (loss) per common share is calculated by dividing net income (loss) by the weighted average number of common shares outstanding combined with dilutive common share equivalents outstanding, if the effect is dilutive.
Potentially dilutive securities were excluded from the calculation of diluted loss per share for the three and six months ended June 30, 2019 and 2018, since including them would have an anti-dilutive effect on loss per share due to the net loss incurred during the periods. Securities convertible into shares of common stock that were not considered in the diluted loss per share calculations were 0.7 million restricted stock units for the three and six months ended June 30, 2019, and 0.9 million restricted stock units for the three and six months ended June 30, 2018.
Note 13 — Fair Value Measurements
Fair value is defined as the amount that would be received for selling an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. The Company categorizes financial assets and liabilities into the three levels of the fair value hierarchy. The hierarchy prioritizes the inputs to valuation techniques used to measure fair value and bases categorization within the hierarchy on the lowest level of input that is available and significant to the fair value measurement.

• | Level 1 — Quoted prices in active markets for identical assets or liabilities;

• | Level 2 — Observable inputs other than Level 1, such as quoted prices for similar assets or liabilities, quoted prices in markets that are not active, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities; and

• | Level 3 — Significant unobservable inputs that are supported by little or no market activity or that are based on the reporting entity’s assumptions about the inputs.

Fair Value of Other Financial Instruments
The carrying amounts of certain financial instruments, including cash and cash equivalents, accounts receivable, accounts payable, and accrued expenses, approximate fair value due to the short-term nature of these accounts. The Company had total cash of $97.5 million, which consisted of cash equivalents of $46.6 million in a government money market account and cash deposits of $45.2 million in an interest bearing demand deposit account and $5.7 million in operating cash accounts, at June 30, 2019, and $3.0 million, which consisted of no cash equivalents and cash deposits of $3.0 million in operating cash accounts, at December 31, 2018.
The carrying amount and estimated fair value of the Company’s long-term debt are as follows (in thousands):

| June 30, 2019 |  | December 31, 2018
| Carrying Amount |  | Fair Value |  | Carrying Amount |  | Fair Value
Borrowings under Credit Facility | — |  |  | — |  |  | 49,731 |  |  | 49,731 |

The carrying amount of borrowings under the Credit Facility approximates its fair value because the interest rates are variable.
Assets Measured at Fair Value on a Nonrecurring Basis
The Company’s non-financial assets, including property and equipment, goodwill, and other intangible assets are measured at fair value on a non-recurring basis and are subject to fair value adjustment in certain circumstances. During the three months ended June 30, 2018, the Company recorded an impairment of $37.2 million for goodwill in the Energy Chemistry Technologies reporting unit. No impairments of any of these assets were recognized during the three and six months ended June 30, 2019.
17

FLOTEK INDUSTRIES, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Note 14 — Income Taxes
A reconciliation of the U.S. federal statutory tax rate to the Company’s effective income tax rate is as follows:

| Three months ended June 30, |  | Six months ended June 30,
| 2019 |  | 2018 |  | 2019 |  | 2018
U.S. federal statutory tax rate | 21.0 | % |  | 21.0 | % |  | 21.0 | % |  | 21.0 | %
State income taxes, net of federal benefit | 1.7 |  |  | 1.0 |  |  | 1.0 |  |  | (0.3 | )
Non-U.S. income taxed at different rates | 0.7 |  |  | (3.5 | ) |  | 1.0 |  |  | 0.3 |
Reduction in tax benefit related to stock-based awards | (1.1 | ) |  | 6.5 |  |  | (1.8 | ) |  | (1.5 | )
Non-deductible expenses | — |  |  | (9.5 | ) |  | (0.3 | ) |  | (9.3 | )
Research and development credit | 0.4 |  |  | (3.9 | ) |  | 0.6 |  |  | 0.6 |
Increase in valuation allowance | (20.7 | ) |  | (42.2 | ) |  | (17.9 | ) |  | (36.0 | )
Other | (0.4 | ) |  | — |  |  | (0.3 | ) |  | — |
Effective income tax rate | 1.6 | % |  | (30.6 | )% |  | 3.3 | % |  | (25.2 | )%

Fluctuations in effective tax rates have historically been impacted by permanent tax differences with no associated income tax impact, changes in the valuation allowance, changes in state apportionment factors, including the effect on state deferred tax assets and liabilities, and non-U.S. income taxed at different rates.
Net deferred tax assets arise due to the recognition of income and expense items for tax purposes, which differ from those used for financial statement purposes. ASC 740, Income Taxes, provides for the recognition of deferred tax assets if realization of such assets is more likely than not. In assessing the need for a valuation allowance in the second quarter of 2018, the Company considered all available objective and verifiable evidence, both positive and negative, including historical levels of pre-tax income (loss) both on a consolidated basis and tax reporting entity basis, legislative developments, and expectations and risks associated with estimates of future pre-tax income. As a result of this analysis, the Company determined that it was more likely than not that it would not realize the benefits of certain deferred tax assets and, therefore, recorded a $15.5 million valuation allowance against the carrying value of net deferred tax assets, except for deferred tax liabilities related to non-amortizable intangible assets and certain state jurisdictions. As all available evidence should be taken into consideration when assessing the need for a valuation allowance, the sale of the CICT segment provided a source of income to support the release of $11.5 million of the valuation allowance which resulted in a deferred tax asset of $18.7 million. As such, the Company reversed this portion of the valuation allowance during the fourth quarter of 2018. The increase in the valuation allowance during the three months ended June 30, 2019, reflects management’s evaluation of deferred tax assets more-likely-than-not to be used after giving consideration to the gain from the sale of the CICT segment and anticipated results of operations.
In January 2017, the Internal Revenue Service notified the Company that it would examine the Company’s federal tax returns for the year ended December 31, 2014. The examination included (1) the corporate returns and (2) employment tax matters. The IRS fieldwork has been completed in relation to the corporate returns with no adverse findings. Further discussion of the employment tax matter can be found in Note 18 — “Related Party Transaction.”
Note 15 — Common Stock
The Company’s Certificate of Incorporation, as amended November 9, 2009, authorizes the Company to issue up to 80 million shares of common stock, par value $0.0001 per share, and 100,000 shares of one or more series of preferred stock, par value $0.0001 per share.
A reconciliation of changes in common shares issued during the six months ended June 30, 2019 is as follows:

Shares issued at December 31, 2018 | 62,162,875 |
Issued as restricted stock award grants | 792,997 |
Shares issued at June 30, 2019 | 62,955,872 |

Stock Repurchase Program
In June 2015, the Company’s Board of Directors authorized the repurchase of up to $50 million of the Company’s common stock. Repurchases may be made in the open market or through privately negotiated transactions. Through December 31, 2018, the
18

FLOTEK INDUSTRIES, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Company had repurchased $0.3 million of its common stock under this authorization. During the three and six months ended June 30, 2019 and 2018, the Company did no t repurchase any shares of its outstanding common stock under this authorization.
At June 30, 2019, the Company has $49.7 million remaining under its share repurchase program.
Note 16 — Business Segment, Geographic and Major Customer Information
Segment Information
Operating segments are defined as components of an enterprise for which separate financial information is available that is regularly evaluated by chief operating decision-makers in deciding how to allocate resources and assess performance. The operations of the Company are categorized into one reportable segment: Energy Chemistry Technologies.
Energy Chemistry Technologies designs, develops, manufactures, packages, distributes, delivers, and markets reservoir-centric fluid systems, including specialty and conventional chemistries, for use in oil and gas (“O&G”) well drilling, cementing, completion, remediation, and stimulation activities designed to maximize recovery in both new and mature fields. Activities in this segment also include construction and management of automated material handling facilities and management of loading facilities and blending operations for oilfield services companies.
The Company evaluates performance based upon a variety of criteria. The primary financial measure is segment operating income. Various functions, including certain sales and marketing activities and general and administrative activities, are provided centrally by the corporate office. Costs associated with corporate office functions, other corporate income and expense items, and income taxes are not allocated to the reportable segment.
Summarized financial information of the reportable segments is as follows (in thousands):

For the three months ended June 30, | Energy Chemistry Technologies |  | Corporate and Other |  | Total
2019 |  |  |  |  |
Net revenue from external customers | $ | 34,692 |  |  | $ | — |  |  | $ | 34,692 |
Income (loss) from operations | (7,651 | ) |  | (6,208 | ) |  | (13,859 | )
Depreciation and amortization | 1,933 |  |  | 186 |  |  | 2,119 |
Capital expenditures | 306 |  |  | — |  |  | 306 |
2018 |  |  |  |  |
Net revenue from external customers | $ | 39,546 |  |  | $ | — |  |  | $ | 39,546 |
Income (loss) from operations | (37,929 | ) |  | (9,211 | ) |  | (47,140 | )
Depreciation and amortization | 1,797 |  |  | 546 |  |  | 2,343 |
Capital expenditures | 1,167 |  |  | 87 |  |  | 1,254 |

For the six months ended June 30, | Energy Chemistry Technologies |  | Corporate and Other |  | Total
2019 |  |  |  |  |
Net revenue from external customers | $ | 77,949 |  |  | $ | — |  |  | $ | 77,949 |
Income (loss) from operations | (12,984 | ) |  | (15,138 | ) |  | (28,122 | )
Depreciation and amortization | 3,718 |  |  | 661 |  |  | 4,379 |
Capital expenditures | 767 |  |  | — |  |  | 767 |
2018 |  |  |  |  |
Net revenue from external customers | $ | 80,615 |  |  | $ | — |  |  | $ | 80,615 |
Income (loss) from operations | (38,095 | ) |  | (18,269 | ) |  | (56,364 | )
Depreciation and amortization | 3,566 |  |  | 1,110 |  |  | 4,676 |
Capital expenditures | 2,178 |  |  | 453 |  |  | 2,631 |

19

FLOTEK INDUSTRIES, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Assets of the Company by reportable segments are as follows (in thousands):

| June 30, 2019 |  | December 31, 2018
Energy Chemistry Technologies | $ | 144,106 |  |  | $ | 139,205 |
Corporate and Other | 119,710 |  |  | 28,208 |
Total segments | 263,816 |  |  | 167,413 |
Held for sale | — |  |  | 118,470 |
Total assets | $ | 263,816 |  |  | $ | 285,883 |

Geographic Information
Revenue by country is based on the location where services are provided and products are used. No individual country other than the United States (“U.S.”) accounted for more than 10% of revenue, except as noted below. Revenue by geographic location is as follows (in thousands):

| Three months ended June 30, |  | Six months ended June 30,
| 2019 |  | 2018 |  | 2019 |  | 2018
U.S. | $ | 31,114 |  |  | $ | 36,176 |  |  | $ | 69,990 |  |  | $ | 72,886 |
Other countries | 3,578 |  |  | 3,370 |  |  | 7,959 |  |  | 7,729 |
Total | $ | 34,692 |  |  | $ | 39,546 |  |  | $ | 77,949 |  |  | $ | 80,615 |

Long-lived assets held in countries other than the U.S. are not considered material to the consolidated financial statements.
Major Customers
Revenue from major customers, as a percentage of consolidated revenue, is as follows:

| Three months ended June 30, |  | Six months ended June 30,
| 2019 |  | 2018 |  | 2019 |  | 2018
Customer A | 17.6 | % |  | * |  |  | 15.4 | % |  | *
Customer B | 11.0 | % |  | 18.2 | % |  | 11.3 | % |  | *
Customer C | * |  |  | * |  |  | 10.7 | % |  | *

* This customer did not account for more than 10% of revenue.
Note 17 — Commitments and Contingencies
Class Action Litigation
On March 30, 2017, the U.S. District Court for the Southern District of Texas granted the Company’s motion to dismiss the four consolidated putative securities class action lawsuits that were filed in November 2015, against the Company and certain of its officers. The lawsuits were previously consolidated into a single case, and a consolidated amended complaint had been filed. The consolidated amended complaint asserted that the Company made false and/or misleading statements, as well as failed to disclose material adverse facts about the Company’s business, operations, and prospects. The complaint sought an award of damages in an unspecified amount on behalf of a putative class consisting of persons who purchased the Company’s common stock between October 23, 2014 and November 9, 2015, inclusive. The lead plaintiff appealed the District Court’s decision granting the motion to dismiss. On February 7, 2019, a three-judge panel of the United States Court of Appeals for the Fifth Circuit issued a unanimous opinion affirming the District Court’s judgment of dismissal in its entirety.
Other Litigation
The Company is subject to routine litigation and other claims that arise in the normal course of business. Management is not aware of any pending or threatened lawsuits or proceedings that are expected to have a material effect on the Company’s financial position, results of operations or liquidity.
20

FLOTEK INDUSTRIES, INC.
NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
Concentrations and Credit Risk
The majority of the Company’s revenue is derived from the oil and gas industry. Customers include major oilfield services companies, major integrated oil and natural gas companies, independent oil and natural gas companies, pressure pumping service companies, and state-owned national oil companies. This concentration of customers in one industry increases credit and business risks.
The Company is subject to concentrations of credit risk within trade accounts receivable, as the Company does not generally require collateral as support for trade receivables. In addition, the majority of the Company’s cash is invested in accounts in two major financial institutions and balances often exceed insurable amounts.
Note 18 — Related Party Transaction
In January 2017, the Internal Revenue Service (“IRS”) notified the Company that it was examining the Company’s federal tax returns for the year ended December 31, 2014. As a result of this examination, the IRS informed the Company on May 1, 2019 that certain employment taxes related to the CEO’s compensation were not properly withheld in 2014 and proposed an adjustment. As the Company has a statutory obligation to collect and withhold employment taxes, management reviewed the CEO’s compensation for tax year 2014, as well as tax years 2015 through 2018, in order to estimate the Company’s potential outstanding employment tax liability in connection with this matter. Upon completion of this review, management believes the Company’s total potential exposure in this matter for 2014 through 2018 is approximately $2.4 million. The CEO’s affiliated companies through which he provided his services have agreed to indemnify the Company for such taxes, and the CEO has executed a personal guaranty in favor of Flotek, supporting this indemnification. As such, the Company recorded an accrued liability for the potential exposure to the IRS in the amount of $2.4 million, with a corresponding receivable, recorded in other current assets, from the CEO’s affiliated companies for the same amount relating to such indemnification obligation.
21

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations
Forward-Looking Statements
This Quarterly Report on Form 10-Q (“Quarterly Report”), and in particular, Part I, Item 2 — “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” contains “forward-looking statements” within the meaning of the safe harbor provisions, 15 U.S.C. § 78u-5, of the Private Securities Litigation Reform Act of 1995 (“Reform Act”). Forward-looking statements are not historical facts, but instead represent Flotek Industries, Inc.’s (“Flotek” or “Company”) current assumptions and beliefs regarding future events, many of which, by their nature, are inherently uncertain and outside the Company’s control. Such statements include estimates, projections, and statements related to the Company’s business plan, objectives, expected operating results, and assumptions upon which those statements are based. The forward-looking statements contained in this Quarterly Report are based on information available as of the date of this Quarterly Report.
The forward-looking statements relate to future industry trends and economic conditions, forecast performance or results of current and future initiatives and the outcome of contingencies and other uncertainties that may have a significant impact on the Company’s business, future operating results and liquidity. These forward-looking statements generally are identified by words including, but not limited to, “anticipate,” “believe,” “estimate,” “continue,” “intend,” “expect,” “plan,” “forecast,” “project,” and similar expressions, or future-tense or conditional constructions such as “will,” “may,” “should,” “could,” etc. The Company cautions that these statements are merely predictions and are not to be considered guarantees of future performance. Forward-looking statements are based upon current expectations and assumptions that are subject to risks and uncertainties that can cause actual results to differ materially from those projected, anticipated, or implied.
A detailed discussion of potential risks and uncertainties that could cause actual results and events to differ materially from forward-looking statements is included in Part I, Item 1A — “Risk Factors” of the Annual Report on Form 10-K for the year ended December 31, 2018 (“Annual Report”) and periodically in subsequent reports filed with the Securities and Exchange Commission (“SEC”). The Company has no obligation to publicly update or revise any forward-looking statements, whether as a result of new information or future events, except as required by law.
Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) should be read in conjunction with the unaudited condensed consolidated financial statements and the related notes thereto of this Quarterly Report, as well as the Annual Report. Phrases such as “Company,” “we,” “our,” and “us” refer to Flotek Industries, Inc. and its subsidiaries.
Basis of Presentation
During the fourth quarter of 2018, the Company classified the Consumer and Industrial Chemistry Technologies segment as held for sale based on management’s intention to sell this business. The Company’s historical financial statements have been revised to present the operating results of the Consumer and Industrial Chemistry Technologies segment as discontinued operations. The results of operations of this segment are presented as “Income from discontinued operations” in the statement of operations and the related cash flows of this segment have been reclassified to discontinued operations for all periods presented. The assets and liabilities of the Consumer and Industrial Chemistry Technologies segment have been reclassified to “Assets held for sale” and “Liabilities held for sale,” respectively, in the consolidated balance sheets for all periods presented. During the first quarter of 2019, the Company completed the sale of this segment.
Executive Summary
Flotek is an international energy chemistry technology-driven company that develops and supplies chemistries and services to the oil and gas industry. Through February 28, 2019, Flotek also provided high value compounds to companies that make food and beverages, cleaning products, cosmetics, and other products that are sold in consumer and industrial markets. Flotek operates in over 15 domestic and international markets.
The Company’s oilfield business includes specialty chemistries and logistics which enable its customers to pursue improved efficiencies in the drilling and completion of their wells. Customers include major integrated oil and gas (“O&G”) companies, oilfield services companies, independent O&G companies, pressure-pumping service companies, national and state-owned oil companies, and international supply chain management companies. Through February 28, 2019, the Company also produced non-energy-related citrus oil and related products, classified as discontinued operations, including (1) high value compounds used as additives by companies in the flavors and fragrances markets and (2) environmentally friendly chemistries for use in numerous industries around the world, including the O&G industry. Additionally, the Company also provides automated bulk material handling, loading facilities, and blending capabilities.
22

Continuing Operations
The operations of the Company are categorized into one reportable segment: Energy Chemistry Technologies (“ECT”).
Energy Chemistry Technologies designs, develops, manufactures, packages, distributes, delivers, and markets reservoir-centric fluid systems, including specialty and conventional chemistries, for use in oil and gas (“O&G”) well drilling, cementing, completion, remediation, and stimulation activities designed to maximize recovery in both new and mature fields. Flotek’s specialty chemistries possess enhanced performance characteristics and are manufactured to perform in a broad range of basins and reservoirs with varying downhole pressures, temperatures and other well-specific conditions customized to customer specifications. This segment has technical services laboratories and a research and innovation laboratory that focus on design improvements, development and viability testing of new chemistry formulations, and continued enhancement of existing products.
Discontinued Operations
In the first quarter of 2019, the Consumer and Industrial Chemistry Technologies segment was sold and is classified as discontinued operations.
Consumer and Industrial Chemistry Technologies designed, developed, and manufactured products that are sold to companies in the flavor and fragrance industries and specialty chemical industry. These technologies are used by beverage and food companies, fragrance companies, and companies providing household and industrial cleaning products.
Market Conditions
The Company’s success is sensitive to a number of factors, which include, but are not limited to, drilling and well completion activity, customer demand for its advanced technology products, market prices for raw materials, and governmental actions.
Drilling and well completion activity levels are influenced by a number of factors, including the number of rigs in operation and the geographical areas of rig activity. Additional factors that influence the level of drilling and well completion activity include:

• | Historical, current, and anticipated future O&G prices,

• | Federal, state, and local governmental actions that may encourage or discourage drilling activity,

• | Customers’ strategies relative to capital funds allocations,

• | Weather conditions, and

• | Technological changes to drilling and completion methods and economics.

Historical North American drilling activity is reflected in “TABLE A” on the following page.
Customers’ demand for advanced technology products and services provided by the Company are dependent on their recognition of the value of:

• | Chemistries that improve the economics of their O&G operations,

• | Chemistries that meet the need of consumer product markets, and

• | Chemistries that are economically viable, socially responsible, and ecologically sound.

Market prices for commodities, including citrus oils, can be influenced by:

• | Historical, current, and anticipated future production levels of the global citrus (primarily orange) crops,

• | Weather related risks,

• | Health and condition of citrus trees (e.g., disease and pests), and

• | International competition and pricing pressures resulting from natural and artificial pricing influences.

Governmental actions may restrict the future use of hazardous chemicals, including, but not limited to, the following industrial applications:

• | O&G drilling and completion operations,

• | O&G production operations, and

• | Non-O&G industrial solvents.

23

TABLE A | Three months ended June 30, |  | Six months ended June 30,
| 2019 |  | 2018 |  | % Change |  |  | 2019 |  | 2018 |  | % Change
Average North American Active Drilling Rigs |  |  |  |  |  |  |  |  |  |  |
U.S. | 989 |  |  | 1,039 |  |  | (4.8 | )% |  | 1,016 |  |  | 1,003 |  |  | 1.3 | %
Canada | 82 |  |  | 108 |  |  | (24.1 | )% |  | 132 |  |  | 188 |  |  | (29.8 | )%
Total | 1,071 |  |  | 1,147 |  |  | (6.6 | )% |  | 1,148 |  |  | 1,191 |  |  | (3.6 | )%
Average U.S. Active Drilling Rigs by Type |  |  |  |  |  |  |  |  |  |  |
Vertical | 50 |  |  | 58 |  |  | (13.8 | )% |  | 56 |  |  | 61 |  |  | (8.2 | )%
Horizontal | 868 |  |  | 914 |  |  | (5.0 | )% |  | 893 |  |  | 874 |  |  | 2.2 | %
Directional | 71 |  |  | 67 |  |  | 6.0 | % |  | 67 |  |  | 68 |  |  | (1.5 | )%
Total | 989 |  |  | 1,039 |  |  | (4.8 | )% |  | 1,016 |  |  | 1,003 |  |  | 1.3 | %
Average North American Drilling Rigs by Product |  |  |  |  |  |  |  |  |  |  |
Oil | 844 |  |  | 899 |  |  | (6.1 | )% |  | 903 |  |  | 929 |  |  | (2.8 | )%
Natural Gas | 227 |  |  | 248 |  |  | (8.5 | )% |  | 247 |  |  | 262 |  |  | (5.7 | )%
Total | 1,071 |  |  | 1,147 |  |  | (6.6 | )% |  | 1,150 |  |  | 1,191 |  |  | (3.4 | )%

Source: Rig counts are per Baker Hughes, Inc. (www.bakerhughes.com). Rig counts are the averages of the weekly rig count activity.
Completions are per the U.S. Energy Information Administration (https://www.eia.gov/petroleum/drilling/) as of July 15, 2019.
Average U.S. rig activity decreased by 4.8% and increased by 1.3% for the three and six months ended June 30, 2019, respectively, when compared to the same periods of 2018, and sequentially, decreased by 5.2% when compared to the first quarter of 2019.
According to data collected by the U.S. Energy Information Administration (“EIA”) as reported on July 15, 2019, completions in the seven most prolific areas in the lower 48 states increased 9.4% and 12.6% for the three and six months ended June 30, 2019, respectively, when compared to the same periods of 2018. Completions increased 5.8% when compared to the first quarter of 2019.
Company Outlook
After a continuous decline in U.S. drilling activity beginning in mid-2014, the market began to gradually recover in the second quarter of 2016. Although oil and gas markets have improved, the level of drilling and completion activity remains lower than previous levels experienced before the downturn in 2014. Assuming the price for crude oil remains relatively soft and regulatory impediments are limited, the Company expects continued volatility in global oilfield activity for the remainder of 2019.
During the second quarter of 2019, the Company continued to analyze and promote the efficacy of its Complex nano-Fluid® (“CnF®”) chemistries and its Prescriptive Chemistry Management® (“PCM®”) offering. Although quarter-to-quarter performance
24

may vary, the Company expects to continue to penetrate the market over time by demonstrating the efficacy of its CnF® chemistries and reservoir-centric full fluid systems via PCM®. The Company will continue to demonstrate the value and benefit of Flotek chemistries through comparative analysis of wells with and without Flotek chemistries and field validation results conducted in partnership with exploration and production (“E&P”) companies. Flotek is experiencing a notable shift in purchasing behaviors in which E&P companies are seeking greater transparency, control and efficacy in their fluid systems, as they see diminishing returns on mechanical factors in their completion designs, such as proppant loading, fluid loading, and lateral length in their completions. As a result, they are focusing more on sourcing consumables, including chemistry, directly from manufacturers and other providers of these products. This trend has created significant changes in Flotek’s customer base, product portfolio, and sales efforts and continues to influence changes in inventory and distribution strategies, capital allocation, and the business model for the Company. While these challenges are expected to persist in the near-term, the Company believes it can grow its client base and revenue opportunities over time.
The Company continues to enhance and improve its patented and proven chemistries through its industry leading research and innovation staff who develop innovative and customer- responsive products, as well as create new chemistry technologies, which are expected to address oilfield challenges of the future and expand the Company’s product lines. Completed in 2016, the Company’s Global Research & Innovation Center in Houston houses scientists, chemists, geologists, and reservoir, petroleum and geomechanical engineers who advance the development of next-generation innovative energy chemistries, as well as expanded collaboration among clients, leaders from academia, and Company scientists. These collaborative opportunities are an important and distinguishing capability within the industry and provide real-time product and fluid system development direct to the consumer.
During the fourth quarter of 2018, the Company initiated a strategic plan to sell its Consumer and Industrial Chemistry Technologies segment, which was completed in the first quarter of 2019. The Company continues to focus on maximizing the profitability of its product and business portfolio, and may exit or enter new product lines or businesses which complement its current operations.
Capital expenditures for continuing operations totaled $0.8 million and $2.6 million for the six months ended June 30, 2019 and 2018, respectively. For the remainder of 2019, the Company expects approximately $2.9 million and does not have any specific growth capital projects currently planned or committed. During the first quarter of 2019, the Company formed a Strategic Capital Committee that will consider these possible growth capital projects going forward. The Company will remain nimble in its core capital expenditure plans, adjusting as market conditions warrant, and will focus any growth capital spending program on uses that generate positive returns and to areas that pose a strategic long-term benefit.
During the first quarter and into the beginning of the second quarter of 2019, the Company lost several key sales personnel. In April 2019, the Company hired a new Senior Vice President of Global Sales & Business Development who now leads the Company’s domestic and international sales and business development strategies. The Company has commenced a process to rebuild and develop a more technically oriented sales organization. As a result of the transition, revenue for the remainder of 2019 may be negatively impacted relative to the first half of the year, as the new sales organization is fully integrated into the organization. The Company believes the opportunity it has taken to enhance the technical background of its sales personnel together with relationships built with its customers, and the demonstrated value and benefit of Flotek’s chemistries will help to mitigate potential revenue declines.
Changes to geopolitical, global economic, and industry trends could have an impact, either positive or negative, on the Company’s business. In the event of significant adverse changes to the demand for oil and gas production, the market price for oil and gas, weather patterns, and/or the availability of citrus crops, the market conditions affecting the Company could change rapidly and materially. Should such adverse changes to market conditions occur, management believes the Company has adequate liquidity to withstand the impact of such changes while continuing to make strategic capital investments and acquisitions, if opportunities arise. In addition, management believes the Company is well-positioned to take advantage of significant increases in demand for its products should market conditions improve dramatically in the near term.
25

Results of Continuing Operations (in thousands):

| Three months ended June 30, |  | Six months ended June 30,
| 2019 |  | 2018 |  | 2019 |  | 2018
Revenue | $ | 34,692 |  |  | $ | 39,546 |  |  | $ | 77,949 |  |  | $ | 80,615 |
Operating expenses (excluding depreciation and amortization) | 38,306 |  |  | 35,544 |  |  | 82,904 |  |  | 72,199 |
Operating expenses % | 110.4 | % |  | 89.9 | % |  | 106.4 | % |  | 89.6 | %
Corporate general and administrative | 6,054 |  |  | 8,665 |  |  | 13,335 |  |  | 17,158 |
Corporate general and administrative % | 17.5 | % |  | 21.9 | % |  | 17.1 | % |  | 21.3 | %
Depreciation and amortization | 2,119 |  |  | 2,343 |  |  | 4,379 |  |  | 4,676 |
Research and development costs | 2,076 |  |  | 2,949 |  |  | 4,360 |  |  | 5,704 |
(Gain)/loss on disposal of long-lived assets | (4 | ) |  | 5 |  |  | 1,093 |  |  | 62 |
Impairment of goodwill | — |  |  | 37,180 |  |  | — |  |  | 37,180 |
Loss from operations | (13,859 | ) |  | (47,140 | ) |  | (28,122 | ) |  | (56,364 | )
Operating margin % | (39.9 | )% |  | (119.2 | )% |  | (36.1 | )% |  | (69.9 | )%
Loss on write-down of assets held for sale | — |  |  | (2,580 | ) |  | — |  |  | (2,580 | )
Interest and other income (expense), net | 677 |  |  | (3,139 | ) |  | (1,214 | ) |  | (3,765 | )
Loss before income taxes | (13,182 | ) |  | (52,859 | ) |  | (29,336 | ) |  | (62,709 | )
Income tax benefit (expense) | 192 |  |  | (16,128 | ) |  | 966 |  |  | (15,807 | )
Loss from continuing operations | (12,990 | ) |  | (68,987 | ) |  | (28,370 | ) |  | (78,516 | )
Income (loss) from discontinued operations, net of tax | (1,608 | ) |  | (6,404 | ) |  | 46,764 |  |  | 3,192 |
Net income (loss) | $ | (14,598 | ) |  | $ | (75,391 | ) |  | $ | 18,394 |  |  | $ | (75,324 | )

Consolidated Results of Operations: Three and Six Months Ended June 30, 2019, Compared to the Three and Six Months Ended June 30, 2018
Consolidated revenue for the three and six months ended June 30, 2019, decreased $4.9 million, or 12.3%, and $2.7 million, or 3.3%, respectively, versus the same periods of 2018. The decrease in revenue was a result of continued volatile macro-environment for U.S. onshore drilling and completion activity, as well as the transition of personnel in the Company’s sales organization, the deferral of completion activity into the third quarter by certain clients, and the utilization of performance-driven pricing programs for a limited number of strategic clients.
Operating expenses (excluding depreciation and amortization) for the three and six months ended June 30, 2019, increased $2.8 million, or 7.8%, and $10.7 million, or 14.8%, respectively, compared to the same periods of 2018, and, as a percentage of revenue, increased to 110.4% and 106.4%, for the three and six months ended June 30, 2019, respectively from 89.9% and 89.6% in the same periods of 2018. The increase is primarily due to increased material and direct labor costs, higher equipment and logistics expenditures, lower plant utilization, and a one-time charge related to the termination of an operations related contract, partially offset by reduced expenses related to the transition in the Company’s sales organization.
Corporate general and administrative (“CG&A”) expenses are not directly attributable to products sold or services provided. CG&A costs decreased $2.6 million, or 30.1%, and $3.8 million, or 22.3%, respectively, for the three and six months ended June 30, 2019, versus the same periods of 2018. As a percentage of revenue, CG&A decreased 4.4% and 4.2% for the three and six months ended June 30, 2019, respectively. The decrease in CG&A costs were primarily due to continuing the aggressive cost reduction measures which began in the last quarter of 2017, decreased consulting expenses associated with the ERP upgrade in 2018, and lower payroll related costs and stock compensation expense associated with reductions in headcount, partially offset by expenses associated with severance and certain shareholder-related activities in the first six months of 2019.
Depreciation and amortization expense decreased $0.2 million, or 9.6%, and $0.3 million, or 6.4%, for the three and six months ended June 30, 2019, respectively versus the same periods of 2018.
Research and Innovation (“R&I”) expense decreased $0.9 million, or 29.6%, and $1.3 million, or 23.6%, for the three and six months ended June 30, 2019, respectively, compared to the same periods of 2018. The decrease is primarily due to lower personnel costs related to the reductions in headcount associated costs savings initiatives.
26

Loss on disposal of long-lived assets remained flat for the three months ended June 30, 2019 but increased $1.0 million for the six months ended June 30, 2019, compared to the same periods of 2018, primarily due to the disposal of certain corporate software in the first quarter of 2019.
Interest and other expense decreased $3.8 million and $2.6 million for the three and six months ended June 30, 2019, respectively, versus the same periods of 2018, primarily due to a $1.2 million write-off associated with the discontinuation of certain corporate projects during the second quarter 2018 and $1.3 million related to moving from an interest expense position to an interest income position as a result of the sale of the CICT segment and subsequent termination of the Amended and Restated Revolving Credit, Term Loan and Security Agreement (as amended, the “Credit Facility”) with PNC Bank in the first quarter 2019. The decrease is partially offset by the acceleration of $1.4 million of unamortized debt issuance costs associated with the termination of the Credit Facility in the first quarter 2019.
The Company recorded an income tax benefit of $0.2 million and $1.0 million, yielding an effective tax benefit rate of 1.5% and 3.3%, for the three and six months ended June 30, 2019, respectively, compared to an income tax provision of $16.1 million and $15.8 million, yielding an effective tax provision rate of 30.5% and 25.2%, for the comparable periods in 2018.
During the fourth quarter of 2018, the Company initiated a strategic plan to sell its Consumer and Industrial Chemistry Technologies segment, which was completed in the first quarter of 2019. The Company recorded net loss from discontinued operations of $1.6 million and net income from discontinued operations of $46.8 million for the three and six months ended June 30, 2019, respectively.
Results by Segment

Energy Chemistry Technologies (“ECT”) |  |  |  |  |  |  |
(dollars in thousands) | Three months ended June 30, |  | Six months ended June 30,
| 2019 |  | 2018 |  | 2019 |  | 2018
Revenue | $ | 34,692 |  |  | $ | 39,546 |  |  | $ | 77,949 |  |  | $ | 80,615 |
Loss from operations | (7,651 | ) |  | (37,929 | ) |  | (12,984 | ) |  | (38,095 | )
Loss from operations - excluding impairment | (7,651 | ) |  | (749 | ) |  | (12,984 | ) |  | (915 | )
Operating margin % | (22.1 | )% |  | (95.9 | )% |  | (16.7 | )% |  | (47.3 | )%

ECT Results of Operations: Three and Six Months Ended June 30, 2019, Compared to the Three and Six Months Ended June 30, 2018
ECT revenue for the three and six months ended June 30, 2019, decreased $4.9 million, or 12.3%, and $2.7 million, or 3.3%, respectively, and versus the same period of 2018. The decrease is primarily a result of the continued volatile macro-environment for U.S. onshore drilling and completion activity, as well as the transition of personnel in the Company’s sales organization, the deferral of completion activity into the third quarter by certain clients, and utilization of performance-driven pricing programs for a limited number of strategic clients.
Loss from operations for the ECT segment improved $30.3 million and $25.1 million for the three and six months ended June 30, 2019, respectively, versus the same period of 2018, which was a result of 2018 including a non-recurring impairment of goodwill of $37.2 million as well as lower inventory adjustments and reduced expenses related to the transition in the Company’s sales organization. The improvement was partially offset by lower gross margin due to lower revenue and gross margin compression due to increased material and direct labor costs, higher equipment and logistics expenditures, lower plant utilization, and a one-time charge related to the termination of an operations related contract.
Discontinued Operations
During the fourth quarter of 2018, the Company classified the Consumer and Industrial Chemistry Technologies segment as held for sale based on management’s intention to sell the business. During the first quarter of 2019, the Company completed the sale of the segment. The Company’s historical financial statements have been revised to present the operating results of the Consumer and Industrial Chemistry Technologies segment as discontinued operations. The information below is presented for informational purposes only.
27

Consumer and Industrial Chemistry Technologies (“CICT”) |  |  |  |  |  |
(dollars in thousands) | Three months ended June 30, |  | Six months ended June 30,
| 2019 |  | 2018 |  | 2019 |  | 2018
Revenue | $ | — |  |  | $ | 19,540 |  |  | $ | 11,031 |  |  | $ | 38,987 |
Income (loss) from operations | — |  |  | 639 |  |  | (610 | ) |  | 3,078 |
Operating margin % | — | % |  | 3.3 | % |  | (5.5 | )% |  | 7.9 | %

Off-Balance Sheet Arrangements
There have been no transactions that generate relationships with unconsolidated entities or financial partnerships, such as entities often referred to as “structured finance” or “special purpose entities” (“SPEs”), established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. As of June 30, 2019, the Company was not involved in any unconsolidated SPEs.
The Company has not made any guarantees to customers or vendors nor does the Company have any off-balance sheet arrangements or commitments that have, or are reasonably likely to have, a current or future effect on the Company’s financial condition, change in financial condition, revenue, expenses, results of operations, liquidity, capital expenditures, or capital resources that would be material to investors.
Critical Accounting Policies and Estimates
The Company’s Financial Statements have been prepared in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). Preparation of these statements requires management to make judgments, estimates, and assumptions that affect the amounts reported in the financial statements and accompanying footnotes. Part II, Item 8 — Financial Statements and Supplementary Data, Note 2 of “Notes to Consolidated Financial Statements” and Part II, Item 7 — Management’s Discussion and Analysis of Financial Condition and Results of Operations, “Critical Accounting Policies and Estimates” of the Company’s Annual Report, and the “Notes to Unaudited Condensed Consolidated Financial Statements” of this Quarterly Report describe the significant accounting policies and critical accounting estimates used to prepare the consolidated financial statements. Critical accounting policies and estimates are defined as those that are both most important to the portrayal of the Company’s financial condition and results of operations and require management’s most subjective judgments. The Company regularly reviews and challenges judgments, assumptions, and estimates related to critical accounting policies. The Company’s estimates and assumptions are based on historical experience and expected changes in the business environment; however, actual results may materially differ from the estimates. There have been no significant changes in the Company’s critical accounting estimates during the six months ended June 30, 2019.
Recent Accounting Pronouncements
Recent accounting pronouncements which may impact the Company are described in Note 2 — “Recent Accounting Pronouncements” in Part I, Item 1 — “Financial Statements” of this Quarterly Report.
Capital Resources and Liquidity
Overview
The Company’s ongoing capital requirements arise from the Company’s need to acquire and maintain equipment, fund working capital requirements, and when the opportunities arise, to make strategic acquisitions and repurchase Company stock. During the first six months of 2019, the Company funded capital requirements primarily with cash on hand, including proceeds from the sale of the CICT segment, and debt financing.
The Company’s primary source of debt financing was its $75 million Credit Facility with PNC Bank. Upon closing of the sale of the CICT segment, on March 1, 2019, the Company repaid the outstanding balance, interest, and fees related to the revolving credit facility, and subsequently terminated the Credit Facility. Significant terms of the Credit Facility are discussed in Note 13 — “Long-Term Debt and Credit Facility” in Part II, Item 8 — “Financial Statements and Supplementary Data” of the Company’s Annual Report.
The Company believes it has adequate liquidity to fund its ongoing operations and capital expenditures. As of June 30, 2019, the Company had available cash and cash equivalents of $97.5 million. For the remainder of 2019, the Company expects maintenance capital spending of approximately $2.9 million and does not have any specific growth capital projects currently planned or committed. During the remainder of 2019, the Company plans to use internally generated funds and cash on hand to fund operations
28

and capital expenditures. With the proceeds from the sale of the CICT segment, the Company paid off its Credit Facility balance and formed a Strategic Capital Committee to evaluate and make recommendations to the board of directors regarding the manner in which the remaining net proceeds from the sale will be deployed. Subject to Board approval of any recommendations by the Strategic Capital Committee, the Company will continue to invest capital in what it believes to be economically attractive opportunities for its shareholders. This includes the potential for share repurchases included under our share repurchase program approved by the board of directors in June 2015.
Any excess cash generated may be used for outside growth opportunities or retained for future use.
Cash Flows
Consolidated cash flows by type of activity are noted below (in thousands):

| Six months ended June 30,
| 2019 |  | 2018
Net cash used in operating activities | $ | (24,510 | ) |  | $ | (19,650 | )
Net cash provided by (used in) investing activities | 168,868 |  |  | (2,722 | )
Net cash (used in) provided by financing activities | (49,911 | ) |  | 20,944 |
Net cash flows provided by discontinued operations | 16 |  |  | 14 |
Effect of changes in exchange rates on cash and cash equivalents | 2 |  |  | (74 | )
Net increase (decrease) in cash and cash equivalents | $ | 94,465 |  |  | $ | (1,488 | )

Operating Activities
Net cash used in operating activities was $24.5 million and $19.7 million during the six months ended June 30, 2019 and 2018, respectively. Consolidated net loss for the six months ended June 30, 2019 and 2018, totaled $28.4 million and $78.5 million, respectively.
During the six months ended June 30, 2019, net non-cash contributions to net income totaled $27.0 million. Contributory non-cash items consisted primarily of $17.9 million for changes to deferred income taxes driven by the valuation allowance recorded against deferred tax assets, $5.8 million for depreciation and amortization, $1.7 million for stock compensation expense, and $1.1 million for net loss on disposal of long-lived assets.
During the six months ended June 30, 2018, net non-cash contributions to net income totaled $66.1 million. Contributory non-cash items consisted primarily of $37.2 million for the goodwill impairment charge, $15.5 million for changes to deferred income taxes driven by the valuation allowance recorded against deferred tax assets, $4.4 million for stock compensation expense, $4.9 million for depreciation and amortization, $2.6 million for the loss on write-down of assets held for sale, and $1.9 million for provisions related to inventory reserves.
During the six months ended June 30, 2019, changes in working capital used $23.2 million in cash, primarily resulting from increasing restricted cash, income taxes receivables and other current assets by $17.2 million and decreasing accounts payable, accrued liabilities and interest payable $14.3 million, partially offset by decreasing accounts receivable and inventories by $7.2 million and increasing income tax payable by $1.2 million.
During the six months ended June 30, 2018, changes in working capital used $7.6 million in cash, primarily resulting from increasing inventory by $2.0 million and decreasing accrued liabilities and interest payable by $16.9 million, partially offset by decreasing accounts receivable, income tax receivable and other current assets by $7.1 million and increasing accounts payable by $4.3 million.
Investing Activities
Net cash provided by investing activities was $168.9 million for the six months ended June 30, 2019. Cash provided by investing activities primarily included $169.7 million of proceeds received from the sale of the CICT segment, partially offset by $0.8 million for capital expenditures and $0.2 million for the purchase of various patents.
Net cash used in investing activities was $2.7 million for the six months ended June 30, 2018. Cash used in investing activities primarily included $2.6 million for capital expenditures and $0.2 million for the purchase of various patents, partially offset by $0.1 million of proceeds received from the sale of long-lived assets.
29

Financing Activities
Net cash used in financing activities was $49.9 million for the six months ended June 30, 2019, due to using $49.7 million for repayments of debt, net of borrowings, associated with the termination of the Credit Facility and $0.1 million for purchases of treasury stock for tax withholding purposes related to the vesting of restricted stock awards.
Net cash generated through financing activities was $20.9 million for the six months ended June 30, 2018, primarily due to receiving $21.2 million for borrowings of debt, net of repayments, and receiving $0.2 million in proceeds from the sale of common stock, partially offset by a loss from noncontrolling interest of $0.4 million.
Contractual Obligations
Cash flows from operations are dependent on a variety of factors, including fluctuations in operating results, accounts receivable collections, inventory management, and the timing of payments for goods and services. Correspondingly, the impact of contractual obligations on the Company’s liquidity and capital resources in future periods is analyzed in conjunction with such factors.
Material contractual obligations consist of payments of finance and operating lease obligations. Contractual obligations at June 30, 2019, are as follows (in thousands):

| Payments Due by Period
| Total |  | Less than 1 year |  | 1 - 3 years |  | 3 - 5 years |  | More than 5 years
Finance lease obligations | 260 |  |  | 70 |  |  | 109 |  |  | 78 |  |  | 3 |
Operating lease obligations | 36,261 |  |  | 2,450 |  |  | 4,615 |  |  | 4,331 |  |  | 24,865 |
Total | $ | 36,521 |  |  | $ | 2,520 |  |  | $ | 4,724 |  |  | $ | 4,409 |  |  | $ | 24,868 |

In addition, the Company executed a long-term supply agreement for terpene product, which serves as a feedstock to some of the Company’s key value-added products. The term of the agreement runs through September 2023, with an option to extend for an additional year. This agreement secures the Company’s access to a sufficient supply of terpene and includes a minimum annual purchase requirement at variable prices during the term of the agreement.
Item 3. Quantitative and Qualitative Disclosures About Market Risk
The Company is exposed to market risk from changes in interest rates, commodity prices, and foreign currency exchange rates. There have been no material changes to the quantitative or qualitative disclosures about market risk set forth in Part II, Item 7A of the Company’s Annual Report.
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
The Company’s disclosure controls and procedures are designed to ensure that information required to be disclosed by the Company in reports filed or submitted under the Securities Exchange Act of 1934, as amended (the “Exchange Act”), is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. The Company’s disclosure controls and procedures are also designed to ensure such information is accumulated and communicated to management, including the principal executive and principal financial officers, as appropriate to allow timely decisions regarding required disclosures. There are inherent limitations to the effectiveness of any system of disclosure controls and procedures, including the possibility of human error and the circumvention or overriding of controls and procedures. Accordingly, even effective disclosure controls and procedures can only provide reasonable assurance that control objectives are attained. The Company’s disclosure controls and procedures are designed to provide such reasonable assurance.
The Company’s management, with the participation of the principal executive and principal financial officers, evaluated the effectiveness of the design and operation of the Company’s disclosure controls and procedures as of June 30, 2019, as required by Rule 13a-15(e) of the Exchange Act. Based upon that evaluation, the principal executive and principal financial officers have concluded that the Company’s disclosure controls and procedures were effective as of June 30, 2019.
Changes in Internal Control Over Financial Reporting
There have been no changes in the Company’s system of internal control over financial reporting during the three months ended June 30, 2019, that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
30

PART II - OTHER INFORMATION
Item 1. Legal Proceedings
Other Litigation
The Company is subject to routine litigation and other claims that arise in the normal course of business. Management is not aware of any pending or threatened lawsuits or proceedings that are expected to have a material effect on the Company’s financial position, results of operations or liquidity.
Item 1A. Risk Factors
See Part I, Item 1A — “Risk Factors" of the Company’s 2018 Annual Report on Form 10-K and Company’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2019 for a detailed discussion of the Company’s risk factors. There have been no material changes to these risk factors.
31

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds
Issuer Purchases of Equity Securities
Repurchases of the Company’s equity securities during the three months ended June 30, 2019, are as follows:

Period | Total Number of Shares Purchased (1) |  | Average Price Paid per Share |  | Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs |  | Maximum Dollar Value of Shares that May Yet be Purchased Under the Plans or Programs (2)
April 1, 2019 to April 30, 2019 | 562 |  |  | $ | 3.30 |  |  | — |  |  | $ | 49,704,947 |
May 1, 2019 to May 31, 2019 | — |  |  | $ | — |  |  | — |  |  | $ | 49,704,947 |
June 1, 2019 to June 30, 2019 | 3,247 |  |  | $ | 3.04 |  |  | — |  |  | $ | 49,704,947 |
Total | 3,809 |  |  | $ | 3.08 |  |  | — |  |  |  |

(1) | The Company purchases shares of its common stock (a) to satisfy tax withholding requirements and payment remittance obligations related to period vesting of restricted shares and exercise of non-qualified stock options, (b) to satisfy payments required for common stock upon the exercise of stock options, and (c) as part of a publicly announced repurchase program on the open market.

(2) | In June 2015, the Company’s Board of Directors authorized the repurchase of up to an additional $50 million of the Company’s common stock. Repurchases may be made in open market or privately negotiated transactions. Through June 30, 2019, the Company has repurchased $0.3 million of its common stock under this authorization and $49.7 million may yet be used to purchase shares.

Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
Not applicable.
Item 5. Other Information
None.
32

Item 6. Exhibits

Exhibit Number |  | Description of Exhibit
2.1 |  | Share Purchase Agreement, dated as of January 10, 2019, by and between the Company and ADM (portions of this exhibit have been omitted pursuant to a confidential treatment request, which has been granted) (incorporated by reference to Exhibit 2.1 to the Company’s Form 8-K filed on March 4, 2019).1
3.1 |  | Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Company’s Form 10-Q for the quarter ended September 30, 2007).
3.2 |  | Certificate of Amendment to the Amended and Restated Certificate of Incorporation (incorporated by reference to Exhibit 3.1 to the Company’s Form 10-Q for the quarter ended September 30, 2009).
3.3 |  | Second Amended and Restated Bylaws, dated October 11, 2017 (incorporated by reference to Exhibit 3.1 to the Company’s Form 8-K filed on October 17, 2017).
4.1 |  | Form of Certificate of Common Stock (incorporated by reference to Appendix E to the Company’s Definitive Proxy Statement filed on September 27, 2001).
4.2 |  | Registration Rights Agreement, dated as of July 26, 2016, by and among the Company, Donald Bramblett, and Mark Kieper (incorporated by reference to Exhibit 4.6 to the Company’s Registration Statement on Form S-3 (File No. 333-212864) filed on August 3, 2016).
10.1 |  | Employment Agreement, dated effective as of April 1, 2019, by and between the Company and John W. Chisholm (incorporated by reference to Exhibit 10.1 to the Company’s Form 8-K filed on May 24, 2019
10.2 |  | First Amended and Restated Employment Agreement, dated effective as of April 1, 2019, by and between the Company and Elizabeth Wilkinson (incorporated by reference to Exhibit 10.2 to the Company’s Form 8-K filed on May 24, 2019)
10.3 |  | Termination and Release Agreement, dated as of May 20, 2019, by and among the Company, John W. Chisholm, Protechnics II, Inc. and Chisholm Management, Inc.
10.4 |  | Stand-Alone Cash-Settled Restricted Stock Unit Agreement, dated as of May 20, 2019, by and between the Company and John W. Chisholm
10.5 |  | Restricted Stock Agreement, dated as of May 24, 2019, by and between the Company and John W. Chisholm
10.6 |  | Form of Restricted Stock Agreement pursuant to the Company’s 2018 Long-Term Incentive Plan.
10.7 |  | Form of Restricted Stock Agreement pursuant to the Company’s 2019 Non-Employee Director Incentive Plan
31.1 | * | Rule 13a-14(a) Certification of Principal Executive Officer.
31.2 | * | Rule 13a-14(a) Certification of Principal Financial Officer.
32.1 | ** | Section 1350 Certification of Principal Executive Officer.
32.2 | ** | Section 1350 Certification of Principal Financial Officer.
101.INS | * | XBRL Instance Document.
101.SCH | * | XBRL Schema Document.
101.CAL | * | XBRL Calculation Linkbase Document.
101.LAB | * | XBRL Label Linkbase Document.
101.PRE | * | XBRL Presentation Linkbase Document.
101.DEF | * | XBRL Definition Linkbase Document.
* |  | Filed herewith.
** |  | Furnished with this Form 10-Q, not filed.
1 |  | Schedules have been omitted pursuant to Item 601(b)(2) of Regulation S-K. The Company undertakes to furnish supplemental copies of any of the omitted schedules upon request by the SEC.
2 |  | Portions of this exhibit have been omitted pursuant to Item 601(b)(10) of Regulation S-K in order for them to remain confidential.

33

SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

FLOTEK INDUSTRIES, INC.
By: |  | /s/ JOHN W. CHISHOLM
|  | John W. Chisholm
|  | President and Chief Executive Officer
Date: | August 7, 2019

FLOTEK INDUSTRIES, INC.
By: |  | /s/ ELIZABETH T. WILKINSON
|  | Elizabeth T. Wilkinson
|  | Chief Financial Officer
Date: | August 7, 2019

34